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ABSTRACT 
Biodegradable polyhydroxybutyrates (PHBs) produced by a wide range of bacteria 
have been considered as an ideal alternative to petroleum-based plastics. Two types of 
mechanistic probes have been synthesized in order to understand the mechanism of 
PHB synthases (PhaCs). The first type is oxo analogs in which the sulfur in the 
coenzyme A (CoA) thioester has been replaced with an oxygen atom. A series of 
3-R-hydroxybutyryl oxo CoA analogs, (HB)nOCoA (n = 1, 2 and 3), were synthesized 
chemoenzymatically in good yields. Two models involving covalent catalysis with 
Cys have been proposed for the chain elongation catalyzed by PhaCs. The first 
involves an active site composed of two monomers in which the growing 
hydroxybutyrate (HB) chain alternates between Cys on each monomer. The second 
involves noncovalent intermediates (HB)nCoA (n ≥ 2). Here the substrate analog 
HBOCoA was successfully employed to trap the noncovalent intermediates in the 
reactions catalyzed by class III PhaC from Allochromatium Vinosum, which supports 
our preferred second mechanistic model. Furthermore, it is also the first time that a 
wild-type (wt) synthase was used to investigate the chain elongation models. 
 
The other type of mechanistic probes is 3-R-hydroxyalkyl CoA that was used to 
investigate the substrate specificity of PhaCs from different classes. Substrate 
availability has been a challenge to study PHB synthases in vitro. Starting with 
commercially available dimethyl S-malate, the intermediate S-ethyl 2-(oxiran-2-yl) 
acetate 23 was synthesized via a ring-opening reaction involving lactone 21 and 
trimethylsilyl iodide followed by an oxidation reaction involving silver oxide. The 
regiospecific ring-opening reaction of epoxide 23 with different organometallic 
reagents afforded a straightforward access to ethyl 3-R-hydroxybutanoates attached 
with a variety of side chains. The final CoA compounds were obtained through the 
thiotransesterification reaction between corresponding benzenethioesters and the thiol 
group in CoA. This synthetic approach provides a new avenue to modifications of 
alkyl groups in 3-R-hydroxyalkyl CoA in an efficient manner.  
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CHAPTER 1 - Design and Synthesis of Mechanistic Probes 
for Trapping Noncovalent Intermediates in 
wt-PhaECAV-Catalyzed Polymerizations 
The paper published in the journal of ACS Chemical Biology (ASAP, DOI: 10.1021/cb5009958) includes this 
work. 
1.1 Introduction 
Petroleum-based plastics have led to environmental problems because they are 
non-biodegradable and environmentally hazardous. A large amount of plastic waste 
accumulates in the oceans and has adverse effects on marine ecosystems. Furthermore, 
combustion of plastic wastes is a common disposal method, resulting in the release of 
harmful pollution-causing wastes into the air.
[1]
 
 
The advent of polyhydroxyalkanoates (PHAs) as promising alternatives to traditional 
plastics has drawn much attention because these materials are biodegradable and can 
be produced by a wide range of bacteria and plants.
[2-3]
 Recently, the 
commercialization of PHAs has been considerably improved by Metabolix, Inc., a 
biological products company, that employs plants such as switchgrass and tobacco to 
produce a large volume of PHAs in the manner that is economically competitive with 
traditional plastics. As a result of its important contribution to the commercialization 
of PHAs, Metabolix, Inc. received the Presidential Green Chemistry Challenge Award 
2 
 
in 2005 and a 6 million-dollar grant from the U.S. Department of Energy in 2011.
[4]
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Scheme 1- 1 Structures of CoA analog and PHAs synthesis by PhaCs 
 
As described in Scheme 1 - 1, polymerizations of 3-R-hydroxyalkanoate-coenzyme A 
(HACoA) are catalyzed by PhaCs, which are representatives of a large number of 
polymerases found in bacteria and can be classified into four categories based on their 
different subunits. PhaECAV investigated in our lab is obtained from Allochromatium 
vinous. This synthase is a class III enzyme composed of two subunits, PhaC and PhaE, 
whose molecular weights are 39 and 40k Da, respectively.
[5-7]
 
 
PhaCs utilize HACoA to generate polyoxoesters, PHAs. Among all substrates, 
3-R-hydroxybutyryl-coenzyme A (HBCoA) bears the simplest chemical structure and 
its synthesis is also relatively simple.
[8]
 These advantages make HBCoA an ideal 
prototype with which to design mechanistic probes for PhaECAV-catalyzed 
polymerizations. 
 
In 2003, Stubbe and coworkers proposed two mechanistic models for polymerization 
reactions of HBCoA catalyzed by PhaCs.
[6]
 Model A was based on an analogy to fatty 
3 
 
acid biosynthesis. As shown in Scheme 1 – 2, histidine (His) initially deprotonates 
cysteine (Cys) for nucleophilic attacks to thioester bonds in HBCoA, resulting in 
formation of covalent intermediates (HB-PhaCs) as well as releases of CoA. An 
aspartate, a general base catalyst in PhaCs, activates one of HB-PhaCs for a 
nucleophilic attack to another. As a result, a growing (HB)n chain is always covalently 
bound to PhaCs and alternates between two active sites. 
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Scheme 1- 2 Proposed mechanistic Model A for formation of PHB 
 
This model requires two active sites to be close to the PhaCs surface. However, the 
lipases crystal structure and the molecular docking of PhaECAV revealed that these 
active sites are deeply buried, rather than close to the surface.
[9-10] 
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Scheme 1- 3 Proposed mechanistic Model B for formation of PHB 
 
Therefore, Model B was proposed as described in Scheme 1 - 3. After formation of 
4 
 
the covalent intermediate HB-PhaCs, an aspartate deprotonates the hydroxyl group in 
HBCoA, rather than the hydroxyl group in HB-PhaCs, for a nucleophilic attack to 
HB-PhaCs. As a result, a noncovalent intermediate (HB)2CoA (highlighted in the box) 
is obtained which subsequently reacylates Cys for the further growth of (HB)n chain. 
 
According to Model B, noncovalent intermediates (HB)nCoA (n ≥ 2) form which in 
contrast are absent in Model A. It seemed straightforward to distinguish between 
these models by detecting the existence of (HB)nCoA in the progress of the 
polymerization reactions. Unfortunately, previous attempts to trap those intermediates 
were not successful, even if a rapid flow-quench apparatus was employed. It is 
because the polymerization rate of HBCoA is much faster than that of initiation.
[11]
 
Therefore, the mechanism for PhaCs remains unclear. Herein, a series of 
3-R-hydroxybutyryl oxo CoA analogs (HB)nOCoA (n = 1, 2 and 3) were designed and 
synthesized to decrease the polymerization rate, making those attempts successful. 
1.2 Results and Discussion 
1.2.1 Design of HBOCoA as a Mechanistic Probe 
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Scheme 1- 4 HBCoA and HBOCoA loading onto PhaECAV via Model B 
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Compared to a native substrate HBCoA, substitution of a sulfur atom in HBCoA with 
an oxygen atom in HBOCoA may greatly decrease the PhaECAV-catalyzed 
polymerization rate because the conversion of oxo esters to thioesters in enzymatic 
(re)acylation steps is predicted to be thermodynamically unfavorable.
[12]
  
1.2.2 Chemoenzymatic Synthesis of (HB)nOCoA (n = 1, 2 and 3) 
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Scheme 1- 5 Chemoenzymatic synthesis of (HB)nOCoA 
 
The synthetic route to (HB)nOCoA (n = 1, 2 and 3) is described in Scheme 1 - 5. 
Starting with D-calcium pantothenate, the 1, 3-diol group in pantothenate was first 
protected with a p-methoxyphenyl group (PMP) to generate acid 1. An amidation of 
carboxylic acid 1 with 2-aminoethanol was accomplished in the presence of ethyl 
chloroformate to generate amide 2. Coupled with carboxylic acids 4, 11 and 16, 
respectively, amide 2 was converted to PMP-protected esters 5, 12 and 17. Depending 
on chemical structures of (HB)n-carboxylic acids 4, 11 and 16, different coupling 
reagents were employed for formation of the corresponding esters. After a removal of 
PMP and benzyl (Bn) protecting groups from these esters in a single step, enzymatic 
precursors 6, 13 and 18 were obtained which were subsequently converted to 
6 
 
(HB)nOCoA (n= 1, 2 and 3) using a chemoenzymatic approach involved a 
combination of three enzymes. Since this thesis mainly focuses on the synthetic route 
to CoA analogs, experimental details are discussed herein. 
 
Although Burkart and coworkers previously synthesized carboxylic acid 1, three steps 
were involved: an acidification of D-calcium pantothenate to the corresponding 
carboxylic acid using the ion exchange resin, a removal of aqueous solution with 
lyophilization and the protection of the residue with a PMP group.
[13]
 Following this 
approach, compound 1 was first prepared in our lab. However, it was found that its 
yield (≤ 30%) was very low because a small amount of water in the residue could 
decrease the yield and it was difficult to dry it completely. To simplify the 
experimental procedure and increase the yield, we first treated a solution of 
D-calcium pantothenate in dry DMF with concentrated H2SO4 followed by the 
addition of p-anisaldehyde dimethyl acetal to generate carboxylic acid 1. This 
modification increased the yield up to 65%. The choice of the PMP rather than a 
dimethyl acetal group as the protecting group to 1, 3 diol was because in the presence 
of Pd(OH)2/C and H2, removals of both of Bn and PMP groups to afford (HB)nOCoA 
precursors, were readily accomplished in a single step with excellent yields.  
 
To obtain amide 2, the first approach seemed straightforward. The amidation of 
carboxylic acid 1 with 2-(benzyloxy) ethanamine was accomplished using coupling 
reagents, 1-ethyl-3-(3- dimethylaminopropyl) carbodiimide (EDCI) and 
7 
 
hydroxybenzotriazole (HOBt). The Bn group was then removed in the presence of 
Pd/C and H2. However, it was found that a hydrogenation with Pd/C and H2 led to a 
partial cleavage of the PMP group. To overcome this problem and simplify the 
synthetic route, we employed an alternative approach. Treated with ethyl 
chloroformate, carboxylic acid 1 was first converted to the corresponding acid 
anhydride. The unprotected 2-aminoethanol then reacted with the acid anhydride to 
generate thermodynamically stable amide 2 with a good yield (76%). Since 
2-aminoethanol contains OH and NH2 groups, concerns of regioselectivity were 
raised for formation of amide 2. It was noted that no ester products were isolated by 
silica gel chromatography. Consequently, the hydrogenation was not required. 
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Scheme 1- 6 Formation of esters 5 and 12 catalyzed by DCC and DMAP 
 
The key step was the esterification between a hydroxyl group in 2 and carboxylic acid 
in (HB)n units (n = 1, 2, and 3). Formation of ester 5 between hydroxyl 2 and 
carboxylic acid 4 was successfully accomplished using N, N-dicyclohexyl- 
carbodiimide (DCC) and 4-dimethylamino pyridine (DMAP). Unfortunately, a 
combination of DCC and DMAP gave rise to unexpected products when they were 
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employed for formation of esters 12 and 17, respectively. For example, esters 5 and 
12 was isolated, when (HB)3 acid 16 was treated with DCC and DMAP followed by 
the addition of hydroxyl 2. No desired ester 17 was observed after purification by 
silica gel chromatography. To obtain desired compounds 12 and 17, corresponding 
acids were first converted to acyl chlorides using oxalyl chloride and a catalytic 
amount of dimethylformamide (DMF) and subsequently treated with hydroxyl 2. This 
method successfully generated the desired esters 12 and 17 with good yields. 
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Scheme 1- 7 Formation of unexpected thioesters using DCC and DMAP 
 
The similar observation is described in Scheme 1 - 7. We were unsuccessful in 
synthesizing (HB)3 thioester when acid 16 analog was treated with DCC and DMAP 
followed by addition of benzenethiol. Purification by silica gel chromatography 
revealed that (HB)2 thioester was a major product rather than (HB)3 thioester. 
Interestingly, in the absence of DMAP, DCC promoted thioester bond formation to 
afford the desired product, (HB)3 thioester. This result is due to the fact that the thiol 
group is more nucleophilic than the hydroxyl group. 
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Scheme 1- 8 Proposed mechanism for formation of the ester (thioester) 
 
Based on these experimental results as well as those of previous work by our lab,
[10]
 I 
proposed a mechanism for formation of esters (or thioester) with one or two HB units 
missing. As described in Scheme 1 – 8, DCC activates carboxylic acid via formation 
of a reactive O-acylisourea intermediate to which DMAP then nucleophilically attacks 
to generate a reactive amide. Subsequently an intramolecular cyclization promoted by 
the next ester bond generates a six-member ring. Under a basic condition, an 
elimination reaction generates a reactive intermediate, (HB)2-DMAP amide, leading 
to a cleavage of one HB unit. The further cyclization may occur to lead to a loss of the 
second HB unit, giving HB-DMAP amide. However, in this case we were not able to 
isolate released HB units due to complicated TLC patterns.  
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Scheme 1- 9 Hydrogenation of 5 with different palladium catalysts 
 
The next step was the hydrogenation of esters 2, 5, 12 and 17 respectively, to afford 
10 
 
enzymatic precursors. The first attempt to remove both Bn and PMP groups in one pot 
was successful by using a combination of palladium catalysts Pd/C and Pd(OH)2/C, 
because Pd/C is generally used to remove a Bn group while Pd(OH)2/C is for a 
removal of a PMP group. This successful experience inspired us to think about if one 
of palladium catalyts could achieve this goal. As described in Scheme 1 - 9, the 
hydrogenation carried out in the presence of H2 and Pd/C for up to 2 days could not 
completely remove the PMP group from compound 5, whereas the Bn group was 
reduced to toluene and removed. In contrast, PMP and Bn groups were quickly 
removed from compound 5 with an excellent yield in the presence of Pd(OH)2/C and 
H2. Notably, the choice of solvents played an important role in determining the 
hydrogenation rate. When this hydrogenation was performed in ethyl acetate, the 
conversion of 5 to enzymatic precursor 6 was not complete even after 48 hr. In 
contrast, methanol could promote this reaction so that it was completed within 12 hr. 
Therefore, we synthesized all enzymatic precursors 6, 13 and 18 in the same manner. 
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Generation of oxo CoA analogs (HOCoA and (HB)nCoA) from enzymatic precursors 
was achieved by three enzymes involved in CoA biosynthesis: a pantothenate kinase 
from Staphylococcus aureus (SaPanK), a phosphopantetheine adenylyltransferase 
(EcCoaD) and a dephospho CoA kinase (EcCoaE) from Escherichia coli. Various 
CoA analogs have been prepared via this approach and applied as inhibitors to 
PhaCs.
[14]
 To an aqueous solution of enzymatic precursors and adenosine triphosphate 
(ATP) was added SaPank followed by EcCoaD and EcCoaE. Reactions were slowly 
stirred at room temperature. To make sure that all enzymatic precursors were 
converted to (HB)nCoA (n = 1, 2 and 3), HPLC running condition was established and 
employed to monitor the progress of enzymatic reactions. The reaction was quenched 
by heating the reaction mixture in a 95 
o
C water bath for 5 min and the precipitated 
protein was removed by centrifugation. Oxo CoA analogs were purified by 
reverse-phase HPLC with reasonable yields (~50%) and fully characterized by 
1
H, 
and 
31
P NMR, gCOSY and HRMS. 
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Scheme 1- 11 Regioselectivity of SaPanK to the HOCoA precursor 
 
It should be noted that since HOCoA precursor contains two primary OH groups at 
both ends, concerns of regioselectivity were raised for the enzymatic conversion. To 
make sure that the phosphate was installed at the desired hydroxyl group by SaPanK, 
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amide 2 in which 1, 3-diol was protected by PMP and there was only one primary OH 
group available, was subjected to phosphorylation using SaPank and ATP. HPLC 
profiles revealed that no reactions occurred in amide 2. In contrast, SaPank was able 
to convert HOCoA precursor to the corresponding phosphate product. These 
experiments demonstrated that SaPank could accept the primary hydroxyl group at the 
pantothenate end rather than that at the aminoethanol end. 
 
1.2.3 Detection of Noncovalent Intermediates (HB)nOCoA (n = 2 - 6) in 
Polymerizations with HBOCoA Catalyzed by wt-PhaECAV  
 OHCoA
O
wt-PhaECAV
HBOCoA HOCoA
O OCoA
O
n
(HB)nOCoA
n = 2 - 6
H
 
Scheme 1- 12 Formation of noncovalent intermediates by PhaECAV via Model B 
 
Based on our hypothesis that the substitution of a sulfur atom with an oxygen atom in 
HBOCoA could decrease the polymerization rate, HBOCoA may serve an informative 
mechanistic probe to study. To detect (HB)nOCoA intermediates in polymerization 
reactions, we incubated wt-PhaECAV (0.1 nM) and HBOCoA (20.0 mM) at 30 
o
C and 
monitored the progress of the reaction by analytical HPLC at the UV wavelength of 
260 nm. As discussed above, according to Model B, noncovalent intermediates 
(HB)nOCoA (n ≥ 2) and HOCoA could form and be detected in the reaction. 
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Figure 1- 1 Formation of HOCoA and (HB)nOCoA during incubation for 1 
(black), 2 (red), 3 (green), 4 (blue), 5 (orange), and 6 hr (pink) 
 
According to time-dependent HPLC profile, the concentration of HBOCoA decreased 
as three new peaks at 9.8, 29.0 and 37.7 min grew. Because HOCoA and (HB)nOCoA 
(n = 2 and 3) were synthesized, their retention times were measured and were 
identical to those of peaks. For the further confirmation of chemical structures of 
HOCoA and (HB)nOCoA (n = 2 and 3), these species from the reaction were isolated 
by HPLC, dried and analyzed by MALDI-TOF MS. Mass spectra confirmed our 
previous assumption that HOCoA, (HB)2OCoA and (HB)3OCoA formed in this 
reaction.  
14 
 
 
Figure 1- 2 MALDI-TOF MS of species at 9.80 (I), 29.0 (II), 37.7 (III) and 
40.0-60.0 min (IV) 
(MALDI-TOF MS was measured by Mr. Benjamin B. Katz and Prof. John M. Tomich) 
 
Consequently, we continued to look for noncovalent intermediates containing more 
HB units. As the HB unit is hydrophobic, these intermediates in HPLC, if there were, 
were predicted to appear after (HB)3OCoA. We pooled, dried and analyzed samples 
eluted at 38.0-60.0 min by MALDI-TOF MS, although no obvious peaks were 
observed at this period. Mass spectra revealed intermediates consisting of up to six 
HB units. MALDI-TOF results and the assignment of corresponding peaks are shown 
in Fig. 1 - 2 and Table 1 - 3. 
 
 
15 
 
 Intermediate MW Assignment 
Calcd. Obsvd. 
I CoAOH 750.131 750.083 [MH]− 
II (HB)2OCoA 922.204 922.360 [MH]
−
 
944.186 944.459 [M2H+Na]− 
III (HB)3OCoA 1008.241 1008.385 [MH]
−
 
1030.223 1030.435 [M2H+Na]− 
IV (HB)4OCoA 1094.278 1094.379 [MH]
− 
(HB)5OCoA 1180.315 1180.493 [MH]
− 
(HB)6OCoA 1266.351 1266.554 [MH]
− 
Table 1- 1 Assignment of corresponding peaks in MALDI-TOF MS spectra 
1.2.4 Extraction of PHB from Polymerizations with CoA Analogs Catalyzed 
by wt-PhaECAV  
Based on our successful detection of noncovalent intermediates as well as our 
hypothesis that wt-PhaECAV may utilize HBOCoA to produce PHB, extraction of PHB 
produced from HBOCoA catalyzed by wt-PhaECAV in vitro was carried out using 
CDCl3.  
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It is well known that wt-PhaECAV utilizes HBCoA to produce PHB. Therefore, 
HBCoA was first employed in a control experiment to establish an extraction 
condition. Polymerization reactions were initiated by adding wt-PhaECAV (5 μM) to a 
buffer containing KPi (pH = 7.8) and HBCoA (10 mM). The mixture was incubated 
overnight at 30 
o
C. Soluble and insoluble fractions were lyophilized to give a white 
powder to which CDCl3 (0.5 mL) was added. The subsequent suspension was heated 
to reflux for 7 days. Vigorously stirring was necessary because extraction happened in 
two phases. During this period, more CDCl3 was added to the suspension to make 
sure its total volume was about 0.5 mL. After being cooled to room temperature, the 
suspension was centrifuged and the supernatant was directly tested by 
1
H NMR. 
1
H 
NMR spectrum showed three peaks which corresponded to the PHB structure. 
 
The polymerization reaction and extraction were performed in the same way as 
HBCoA using HBOCoA (10 mM) and PhaECAV (100 μM). However, no PHB was 
observed in 
1
H NMR spectra, as shown in Fig. 1 - 3 (top).  
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Figure 1- 3 
1
H NMR spectra of PHB isolated from in vitro polymerization 
reactions using HBOCoA (top one) and HBCoA (bottom one) 
 
Other attempts to look for generation of PHB from HBOCoA via MALDI-TOF MS 
and gel permeation chromatography (GPC) were unsuccessful. These unsuccessful 
experiments may be due to enzyme-catalyzed hydrolysis of (HB)nOCoA. 
1.3 Conclusion 
Through chemoenzymatic approaches with several modifications, the first type of 
mechanistic probes, (HB)nOCoA was synthesized with good yields. Their structures 
were fully characterized by 
1
H, gCOSY and HRMS. The substitution of a sulfur atom 
in HBCoA with an oxygen atom in HBOCoA greatly decreased the polymerization 
rate. This decreased rate enabled us to successfully detect formation of noncovalent 
intermediates in reactions catalyzed by wt-PhaECAV. These results strongly supported 
our preferred mechanistic model. Furthermore, it is also the first time that a wild-type 
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synthase was used to investigate the chain elongation models. 
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CHAPTER 2 - Synthetic Studies of CoA Analogs for 
Substrate Specificity Studies  
2.1 Introduction 

 O

R O
n
R = Me, PHB
       Et,  PHV
 
Scheme 2- 1 Chemical structures of PHAs 
 
Based on the exciting results described in Chapter 1, our preferred mechanistic model 
for wt-PhaECAV-catalyzed polymerizations has been confirmed. In the following 
project, we extended the library of synthetic CoA analogs containing varied chain 
length and functional groups for polymerizations catalyzed by class I and III PHA 
synthases. Through modification of R groups in PHAs, polymer properties can be 
modified for specialty applications. It is well known that 125 different 
hydroxyalkanoic acids can be used to produce polyoxoesters through a variety of 
organisms.
[15]
 For example, poly (3-hydroxybutyrate-co- 3-hydroxy- valerate) (PHBV) 
produced by Ralstonia eutropha under certain conditions has linear thermoplastic and 
aliphatic properties.
[16]
 Functional groups-modified CoA analogs are also required for 
mechanistic purposes. In this project, we also introduced ethynyl and azide groups to 
CoA analogs that could load onto PHA synthases. When exposed to UV light, the 
onset of a click Huisgen cycloaddtion reaction occurs between these functional groups 
which in turn covalently couples synthases involved. As substrate specificity studies 
are in progress and this thesis mainly focuses on synthetic approaches, details of the 
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organic synthesis involved are discussed herein. 
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Scheme 2- 2 Chemical structures of CoA analogs synthesized in this project 
 
Because class I and III PHA synthases utilize HBCoA as a native substrate to generate 
PHB, it is logical to consider HBCoA an ideal prototype to design a series of CoA 
analogs. According to our study about mechanistic Model B, a coenzyme A in 
HBCoA is necessary to load HB units onto active sites in PhaCs. A hydroxyl group in 
HBCoA is also required for the HB chain growth in polymerization reactions. The 
only part in HBCoA that can be modified is the R group. In this project, we designed 
and evaluated several synthetic routes to introduce various R groups into CoA 
analogs. 
2.2 Results and Discussion 
2.2.1 Design and Synthesis of (S)-S-phenyl 2-(oxiran-2-yl) Ethanethioate as 
a Key Synthetic Intermediate 
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Scheme 2- 3 Retrosynthetic analysis of CoA analogs 
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A retrosynthetic analysis of CoA analogs is described in Scheme 2 - 3. Our previous 
experience of HBCoA synthesis demonstrated that thiotransesterification of 
3-R-hydroxy thioesters with a thiol group in CoA provides efficient access to 
synthesis of CoA analogs. Since 3-R-hydroxyesters are commonly prepared by the 
ring-opening reaction of optically pure epoxyesters with organometallic reagents,
[17] 
it 
was anticipated that a ring-opening reaction of an epoxythioester (TM 1) performed in 
the same manner as epoxyesters may also afford an access to 3-R-hydroxythioesters.  
 
To generate TM 1, we designed and investigated two methods. The first method was 
based on publications in which oxidation reactions of optically pure iodohydrins with 
Ag2O were able to provide enantiomerically pure epoxyesters.
[17]
 The second one was 
deduced from well-established experimental procedures in which an oxidation of 
carbon-carbon double bonds with oxidizers like meta-chloroperoxybenzoic acid 
(m-CPBA) and H2O2 followed by a hydrolytic kinetic resolution using the Jacobsen’s 
salen Co (III) catalyst was able to provide enantiomerically pure epoxyesters.
[18]
 
Unfortunately, it was found that neither of these methods afforded the desired 
products.  
I
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O
O
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Me3SiI
Ph-SH Ph S
O O
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Scheme 2- 4 Synthesis of TM 1 via Method 1 
 
To a solution of benzenethiol and hydroxylactone 21 in dry CH2Cl2 was slowly added 
Me3SiI. The mixture was stirred overnight at room temperature followed by a 
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work-up that successfully afforded the synthetic intermediate iodothioester although 
its isolated yield was about 30%. Unfortunately, Ag2O was unable to convert the 
iodothioester to the corresponding epoxide (TM 1). This is probably due to the fact 
that a sulfur atom in it may poison Ag2O.
[19]
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Scheme 2- 5 Synthesis of TM 1 via Method 2 
 
In the second method, formation of a thioester between but-3-enoic acid and 
benzenethiol was easily accomplished in the presence of DCC and DMAP as coupling 
reagents. However, the oxidation of a carbon-carbon double bond with m-CPBA or 
H2O2 led to complicated results (checked with TLC plates). This complexity may be 
because these oxidizers also oxidized thioester to sulfinyl or sulfonyl groups.
[20] 
We 
did not test other peroxide compounds (CF3CO3H, t-BuOOH, etc.) known to be able 
to oxidize carbon-carbon double bonds to generate epoxides. 
2.2.2 Design and Synthesis of (S)-ethyl 2-(oxiran-2-yl) Acetate as a Key 
Synthetic Intermediate 
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Scheme 2- 6 Synthesis of epoxide 23 
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Due to unsuccessful attempts to prepare TM 1, epoxide 23 was designed and 
synthesized as an alternative synthetic intermediate to TM 1, as shown in Scheme 2 - 
6. It is well known that a ring opening reaction of epoxide 23 with organometallic 
reagents was able to introduce various R groups to hydroxyesters.
[21]
 As 
enantiomerically pure hydroxyesters (highlighted in the box) are important synthetic 
intermediates, a variety of methodologies for their generation were developed. 
Unfortunately, these methods require expensive catalysts and specific instruments. 
For example, the enantioselective Reformastsky reaction using aldehydes and 
α-halogenated esters is able to afford hydroxyesters, but catalysts involved are not 
commercially available.
[22]
 Enantioselective hydrogenation of β-keto esters with H2 
and RuCl3 (R)-SYNPHOS must be performed under the high pressure (10 - 50 bar).
[23]
 
These disadvantages limit these methodologies available within certain organic labs. 
Therefore, an efficient synthetic route is still required. Starting with dimethyl 
(s)-malate, a regioselective reduction reaction of the dimethyl ester to 1, 2-diol 
product 20 was accomplished using borane-dimethyl sulfide complex (BH3·Me2S) 
and a catalytic amount of sodium tetrahydroborate (NaBH4).
[24]
 Addition of NaBH4 
greatly increased the reduction rate, although BH3·Me2S could also afford the desired 
product. After the reaction was quenched with methanol, all solvents were removed to 
give crude product 20 which was used in the second step without further purification. 
The lactonization of 20 was carried out with a catalytic amount of trifluoroacetic acid 
(TFA) to afford hydroxylactone 21. It should be noted that the onset of polymerization 
of 21 may occur and lead to a low yield, if this reaction was performed at 35 °C or 
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higher temperature. However, 
1
H NMR result demonstrated that starting material 20 
was still present even when this reaction was stirred at 20 °C for 48 hr. Therefore, the 
reaction temperature should be carefully controlled at a range of 24-28 °C to obtain a 
good yield. Upon treating 21 with absolute ethanol and Me3SiI, iodohydrin 22 was 
obtained with a high yield (95%, based on 21). We did not observe the presence of 
any TMS-protecting products after the isolation via silica gel chromatography, 
although Me3SiI is prone to introducing a trimethylsilyl group to a hydroxyl group. 
The conversion of iodohydrin 22 to epoxide 23 was accomplished with Ag2O upon 
refluxing for 4 hr. Interestingly, a suspension of 22 and Ag2O in dimethoxyethane 
(DME) was able to afford the desired epoxide 23 while the same reaction preformed 
in acetonitrile (MeCN) failed to generate the epoxide. This failure is likely because 
DME has a higher boiling point than that of MeCN. 
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Scheme 2- 7 Regioselectivity of the ring-opening epoxide reaction 
 
The synthesis of enantiomerically pure hydroxyesters was accomplished via the 
ring-opening epoxide reaction. This reaction is subjected to SN1 or SN2 mechanisms, 
depending on reaction conditions.
[25]
 If the chemical structure of an epoxide, like 
compound 23, is asymmetric, concerns of regioselectivity are raised for the 
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ring-opening reaction. Under acidic reaction conditions, the acid-catalyzed 
ring-opening reaction mainly undergoes an SN1 mechanism to give more substituted 
products. Protonation of the oxygen in the epoxide by acids creates a good leaving 
group. The partially positive charge positions on the more substituted carbon which is 
subsequently attacked by nucleophiles. In contrast, the ring-opening reaction occurs 
via an SN2 mechanism under basic reaction conditions, and the nucleophile attacks the 
less substituted carbon to open the epoxide. Because organometallic reagents are 
nucleophilic, ring-opening epoxide reactions with them affords access to the less 
substituted addition products. 
O
OO
O
OOH
R
23
(R)2CuM
M R Solvent Yield%No.
24
30
36
48
Mg CH3 THF/ether
THF/ether
THF/ether
THF/ether
Mg
Li
Mg
67
65
56
54
42 Mg Ph- THF/ether 45
[α]D
20(MeOH) lit.[α]D
20
-6.4o
-7.3o
-11.4o
-15.4o
-9.9o
-16.6o (CHCl3)
-6.0o (MeOH)
-2.45o (CHCl3)
-14.5o (MeOH)
-22.5o (CHCl3)
 
Scheme 2- 8 Synthesis of enantiomerically pure hydroxyesters via 
organocuprates 
[26]
 
 
Preparation of enantiomerically pure hydroxyesters with epoxide 23 by way of 
ring-opening epoxide reactions using organocuprates is described in scheme 2 - 8. As 
epoxide 23 contains an ethyl ester bond subjected to an attack by lithium or Grignard 
reagents, these metallic reagents should first be converted to organocuprates which 
are able to open epoxides to obtain desired hydroxyesters in which ethyl ester bonds 
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retain. This reaction occurs as a result of the relative reactivity of organocuprates to 
various functional groups (RCOCl > RCHO > epoxides >> ketones > esters).
[21]
 
  
Generation of the corresponding cuprates from a copper bromide dimethyl sulfide 
complex (CuBr·Me2S) was accomplished using lithium and Grignard reagents, 
respectively. At -60 °C, to a suspension of CuBr·Me2S (1.1 eq) in dry THF/ether (v/v 
= 1:2) were added lithium or magnesium reagents (2.2 eq). To make sure that lithium 
or Grignard reagents were completely consumed, the reaction was warmed to -25 - 
-30 °C and the mixture was stirred vigorously for 1 h. If the conversion of metallic 
reagents to their corresponding cuprates was not complete, the remaining of metallic 
reagents may attack ethyl ester bonds, leading to formation of ketones. Epoxide 23 
was then added and the mixture was stirred at -25 - -30 °C for 4 hr. Finally, the 
reaction was quenched at 0 
o
C by adding saturated ammonium chloride (NH4Cl) 
solution when epoxide 23 was completely consumed (checked with TLC plates). 
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Scheme 2- 9 Synthesis of enantiomerically pure hydroxyester 54 
 
It is well known that regiospecific addition of alkynylaluminum reagents to epoxides 
is able to provide less substituted-carbon addition products.
[27]
 To obtain an ethynyl 
aluminum reagent, ethynyl trimethylsilane was treated with n-butyllithium at - 45 °C 
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to afford the corresponding lithium reagent, which subsequently reacted with 
diethylaluminum chloride. The mixture was stirred vigorously at 0 °C for 1 h to 
convert ethynyl lithium to an ethynylaluminum reagent. Epoxide 23 was then added 
and the mixture was stirred at 0 °C for 4 hr. The reaction was quenched by adding of 
diluted HCl followed by saturated NH4Cl when epoxide 23 was completely consumed. 
The chemical structure of 54 was fully characterized with 
1
H NMR, 
13
C NMR and 
gCOSY. 
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Scheme 2- 10 Synthesis of CoA analogs 
 
After formation of carbon-carbon bonds between organometallic reagents and the 
epoxide via ring-opening reactions, following steps to generate CoA analogs were the 
same as the synthetic route to HBCoA.
[8]
 Under basic conditions, TBDMS- (TIPS- for 
ethynyl CoA analog) groups were employed to protect the hydroxyl groups in 
hydroxyesters. Hydrolysis of corresponding ethyl esters with NaOH followed by 
dilute HCl was able to afford carboxylic acids, which were subsequently coupled with 
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benzenethiol to obtain thioesters in the presence of DCC and DMAP. Diluted 
hydrofluoric acid (5% HF in MeCN) was utilized to quickly remove TBDMS- (TIPS-) 
protecting groups to give CoA precursors. To synthesize desired CoA analogs, we 
added CoA precursors (5 - 10 eq) to a solution of coenzyme A CoA (1 eq) in a basic 
buffer (Kpi, 50 Mm; pH = 9.5). Excess precursors were able to push the equilibrium 
of the reaction to products.
[28]
 After 95% of CoA was converted to products (checked 
with analytical HPLC), we extracted excess CoA precursors as well as benzenethiol 
by adding ether. Further purification of final CoA analogs was accomplished with a 
semi-preparative HPLC column. By the way, CoA analog 65 consisting of an azide 
group was also obtained in the same manner. The structures of final compounds were 
fully characterized by 
1
H NMR, 
31
P NMR and MALDI-TOF MS. For more 
information, see Experimental Procedure. 
CoA analog Calcd. MW Obsvd. MW Assignment 
S
OH O
CoA  
867.65 866.188 [M-H]
-
 
S
OH O
CoA   
881.68 880.224 [M-H]
-
 
S
OH O
CoA
Bu
 
909.73 908.229 [M-H]
-
 
S
OH O
CoA
Ph
 
929.72 928.174 [M-H]
-
 
S
OH O
CoA  
879.66 878.807 [M-H]
-
 
S
OH O
CoA  
877.15 876.119 [M-H]
-
 
S
OH O
CoA
N3
 
894.64 893.015 [M-H]
-
 
Table 2- 1 MALDI-TOF MS analysis of CoA analogs 
 (MALDI-TOF MS was measured by Mr. Benjamin B. Katz and Prof. John M. Tomich) 
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2.3 Conclusion 
Herein, we established a novel synthetic route to CoA analogs. Through the 
regiospecific ring-opening reaction of (S)-ethyl 2-(oxiran-2-yl)acetate with 
organometallic reagents, introduction of various functional groups to enantiomerically 
pure hydroxyesters was accomplished using organometallic reagents. The overall 
yield of this method was reasonable (CoA analog 29 for instance, 21% for 10 steps). 
Substrates specificity studies of the PHA synthases are in progress and will be 
reported in due course. 
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Experimental Procedure 
General Method: All chemicals were purchased at the highest purity grade. All 
solvents were anhydrous. All reactions were performed under argon atmosphere 
unless otherwise specified. Thin layer chromatography (TLC) was performed using 
60 mesh silica gel plates and visualization was performed using short wavelength UV 
light (254 nm) and basic KMnO4 staining. NMR spectra were recorded on a Varian 
400 MHz spectrometer. Chemical shifts of proton (
1
H NMR) were reported in ppm 
relative to the residual solvent peaks (CDCl3, 7.26 ppm; D2O, 4.80 ppm). Chemical 
shifts of phosphorus (
31
P NMR) were reported in ppm relative to the external 
reference of 85% H3PO4 (0.00 ppm). MALDI-TOF and high-resolution mass 
spectroscopies were recorded on Bruker Ultra Flex II and Q-Star Elite spectrometers, 
respectively. 
H
N
COO-
 
O
Ca2+
2
H2SO4
10-camphorsulfonic acid
p-anisaldehyde dimethyl acetal
DMF
O O
PMP
H
N
COOH
O
O O
PMP
H
N
O
H
N
OH
O
HO
NH2
ClCOOEt
CH2Cl2
O OH
O
O OBn
O
HO OBn
Obenzyl 2,2,2-trichloroacetimidate
trifluoro methane sulfonic acid
cyclohexane/dichloromethane
NaOH
H2O/ethnol
DCC, DMAP
CH2Cl2
O O
PMP
H
N
O
H
N
O
O
OBn
O
H2, Pd(OH)2/C
MeOH
OH OH
H
N
O
H
N
O
O
OH
OSaPanK, EcCoaD, 
EcCoaE, ATP
buffer
HBOCoA
1 2
3
4
567
Scheme 3 - 1. Chemoenzymatic synthesis of HBOCoA 7 
 
3-((4R)-2-(4-methoxyphenyl)-5,5-dimethyl-1,3-dioxane-4-carboxamido)- 
propanoic acid (1). D-Calcium pantothenate (10 g, 38.7 mmol) in dry DMF (250 mL) 
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was treated with con. H2SO4 (2.22 mL). After 30 min, 10-camphorsulfonic acid (0.5 g, 
2.1 mmol) and p-anisaldehyde dimethyl acetal (7.3 mL, 42.8 mmol) were added and 
the reaction was stirred overnight at room temperature. Concentration was 
accomplished under a reduced pressure. The residue was dissolved in ethyl acetate. 
The organic layer was washed with brine, dried with Na2SO4 and concentrated under 
reduced pressure. The residue was purified by silica gel chromatography 
(hexane/EtOAc= 6/1 to 1/1) to afford the pure product 1 as a white solid (8.4 g, 65%). 
1
H NMR (400 MHz, CDCl3) δ: 7.41 (d, 2H, J = 8.0 Hz), 7.02 (t, 1H, J = 12.0 Hz), 
6.91 (d, 2H, J = 8.0 Hz), 5.46 (s, 1H), 4.09 (s, 1H), 3.81 (s, 3H), 3.68 (dt, 2H, J = 12.0, 
8.0 Hz), 3.53 (m, 2H), 2.61 (t, 2H, J = 8.0 Hz), 1.10 (s, 3H), 1.09 (s, 3H). 
 
(4R)-N-(3-((2-hydroxyethyl)amino)-3-oxopropyl)-2-(4-methoxyphenyl)-5,5-dimet
hyl-1,3-dioxane-4- carboxamide (2). A solution of PMP-group protected 
D-pantothenic acid 1 (4.0 g, 11.8 mmol) in dry CH2Cl2 (150 mL) was treated with 
ethyl chloroformate (1.42 g, 13.0 mmol) for 10 min. Then 2-amino ethanol (0.87 g, 
14.2 mmol) was added followed by pyridine (1.62 g, 16.5 mmol) and the mixture was 
stirred overnight at room temperature. The organic layer was washed with brine, dried 
with Na2SO4 and concentrated under reduced pressure. The residue was purified by 
silica gel chromatography (hexane/EtOAc = 6/1 to 3/1) to afford the pure product 2 as 
a white solid (3.40 g, 76%). 
1
H NMR (400 MHz, CDCl3) δ: 7.43 (d, 2H, J = 8.0 Hz), 
7.03 (br, 1H), 6.93 (d, 2H, J = 8.0 Hz), 6.47 (br, 1H), 5.46 (s, 1H), 4.08 (s, 1H), 3.82 
(s, 3H), 3.72 (d, 1H, J = 12.0 Hz), 3.69 (d, 1H, J = 12.0 Hz), 3.64 (m, 2H), 3.55 (dt, 
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2H, J = 12.0, 8.0 Hz), 3.40 - 3.34 (m, 2H), 2.85 (t, 1H, J = 4.0 Hz), 2.45 (t, 2H, J = 
4.0 Hz), 1.11 (s, 3H), 1.09 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ: 171.91, 170.01, 
160.43, 130.21, 127.67, 113.91, 101.50, 83.95, 78.57, 62.15, 55.48, 42.58, 36.45, 
35.23, 33.23, 21.98, 19.26. 
 
(R)-ethyl 3-(benzyloxy)-butanoate (3). To a solution of (R)-ethyl 
3-hydroxybutanoate (17.0g, 0.13 mol) and benzyl 2, 2, 2-trichloroacetimidate (39.0 g, 
0.15 mol) in cyclohexane/dichloromethane (170 mL / 85 mL) was added trifluoro 
methane sulfonic acid (1.7 mL) at 0 °C. The reaction was stirred overnight at room 
temperature. After filtration, the organic layer was washed with saturated NaHCO3 
solution and brine, dried with Na2SO4 and concentrated under reduced pressure. The 
residue was purified by silica gel chromatography (Hexane/ EtOAc = 40/1) to afford 
the pure product 3 (17.0 g, 60%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 
7.33 (m, 5H), 4.54 (dd, 2H, J = 12.0 Hz), 4.15 (m, 2H), 4.02 (m, 1H), 2.64 (dd, 1H, J 
= 16.0 Hz, 8.0 Hz), 2.42 (dd, 1H, J = 16.0, 4.0 Hz), 1.27 (m, 6H); 
13
C NMR (100 
MHz, CDCl3) δ: 171.7, 138.8, 128.6, 127.7, 72.3, 71.0, 60.6, 42.4, 20.1, 14.5. 
 
(R)-3-(benzyloxy)butanoic acid (4). To a solution of compound 3 (17.2 g, 77.3 mmol) 
in ethanol (230 mL) was added NaOH aqueous (120 mL, 386.9 mmol). The mixture 
was stirred at 50 °C for 2 h. Ethanol was removed under a reduced pressure. The pH 
value of aqueous residue was adjusted to 3.0 by adding HCl. Then water residue was 
extracted with dichloromethane. The combined organic layers was washed with brine, 
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dried with Na2SO4 and concentrated under reduced pressure to afford the pure product 
4 (14.9 g, 99%) as a colorless oil which was used in the next step without further 
purification. 
1
H NMR (400 MHz, CDCl3) δ: 7.38 (m, 5H), 4.61 (dd, 2H, J = 12.0 Hz), 
4.07 (m, 1H), 2.72 (dd, 1H, J = 12.0 Hz, 4.0 Hz), 2.57 (dd, 1H, J = 16.0 Hz, 8.0 Hz), 
1.35 (d, 3H, J = 8.0 Hz). 
 
2-(3-((4R)-2-(4-methoxyphenyl)-5,5-dimethyl-1,3-dioxane-4-carboxamido)propan
amido)ethyl(3R)-3-(benzyloxy)butanoate (5). To a solution of carboxylic acid 4 
(0.60 g, 3.09 mmol) in dry CH2Cl2 (25 mL) were added DCC (0.93 g, 4.63 mmol) and 
catalytic amount of DMAP. After 10 min, alcohol 2 (1.17g, 3.09 mmol) in dry CH2Cl2 
(5 mL) was added and the mixture was stirred overnight at room temperature. After 
filtration, the filtrate was washed with brine, dried with Na2SO4 and concentrated 
under reduced pressure. The residue was purified by silica gel chromatography 
(CH2Cl2/MeOH = 50/1 to 20/1) to afford the pure product 5 as a colorless oil (1.46 g, 
84.9%). 
1
H NMR (400 MHz, CDCl3) δ: 7.42 (d, 2H, J = 8.0 Hz), 7.30 (m, 5H), 7.01 (t, 
1H, J = 4.0 Hz), 6.92 (d, 2H, J = 8.0 Hz), 6.01 (t, 1H, J = 4.0 Hz), 5.45 (s, 1H), 4.58 
(d, 1H, J = 12.0 Hz), 4.46 (d, 1H, J = 12.0 Hz), 4.13 (m, 2H), 4.11 (s, 1H), 4.06 (m, 
1H), 3.81 (s, 3H), 3.68 (dt, 2H, J = 24.0, 12.0 Hz), 3.45 (m, 4H), 2.61 (m, 1H), 2.50 
(m, 1H), 2.25 (m, 2H), 1.28 (d, 3H, J = 8.0 Hz), 1.09 (s, 6H); 
13
C NMR (100 MHz, 
CDCl3) δ: 171.48, 171.08, 169.53, 160.35, 138.40, 130.29, 128.56, 127.87, 127.81, 
127.62, 113.86, 101.43, 83.95, 78.61, 72.21, 71.93, 63.33, 55.45, 41.94, 38.61, 35.85, 
34.92, 33.19, 21.97, 19.81, 19.25. 
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(R)-4-(2-(3-((R)-2,4-dihydroxy-3,3-dimethylbutanamido)propanamido)ethoxy)-4-
oxobutan-2-yl(R)-3-hydroxybutanoate (6). In the presence of H2 and Pd(OH)2/C 
(20 mg), a solution of ester 5 (0.20 g, 0.36 mmol) in MeOH (10 mL) was stirred 
vigorously overnight at room temperature. After filtration, the filtrate was 
concentrated under reduced pressure. The residue was purified by silica gel 
chromatography (CH2Cl2/MeOH= 20/1 to 10/1) to afford the pure product 6 as a 
colorless oil (0.12 g, 95.7%). 
1
H NMR (400 MHz, CDCl3) δ: 7.41 (t, 1H, J = 4.0 Hz), 
6.78 (t, 1H, J = 4.0 Hz), 4.34 (d, 1H, J = 4.0 Hz), 4.32 - 4.23 (m, 2H), 4.17 (dq, 1H, J 
= 12.0, 4.0 Hz), 4.00 (d, 1H, J = 4.0 Hz), 3.93 (d, 1H, J = 4.0 Hz), 3.72 - 3.56 (m, 3H), 
3.52 - 3.44 (m, 3H), 3.40 - 3.33 (m, 1H), 3.99 (d, 1H, J = 4.0 Hz), 3.93 (s, 1H), 3.72 - 
3.56 (m, 3H), 3.52 - 3.43 (m 2H), 3.40 - 3.32 (m, 1H), 2.53 - 2.36 (m, 4H), 1.26 (d, 
3H, J = 8.0 Hz), 1.01 (s, 3H), 0.91 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ: 174.56, 
172.58, 172.09, 77.72, 70.98, 65.01, 63.43, 43.97, 39.47, 38.76, 36.05, 35.61, 23.23, 
21.77, 20.48. 
 
Enzymatic Synthesis of HBOCoA (7). A 2-mL reaction mixture consisted of 
precursor 6 (20.0 mM), ATP (50.0 mM), MgCl2 (10.0 mM), SaCoaA (80.0 μg), 
EcCoaD (80.0 μg) and EcCoaE (80.0 μg) in 100 mM Tris-HCl (pH = 7.60). The 
reaction was initiated by addition of the enzymes and incubated at 37 °C for 3 h. The 
reaction was quenched by heating the reaction mixture in a 95 °C water bath for 5 min, 
and the precipitated protein was removed by centrifugation (14,000 rpm x 5 min). The 
supernatant was loaded onto a semi-preparative HPLC column (Luna C18-2, 5 μm, 10 
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mm × 250 mm) that was eluted at 3.00 mL/min using a linear gradient from 5 to 90% 
methanol in 10.0 mM ammonium acetate (pH = 5.00) over 60 min. The fractions 
containing the product were pooled, concentrated, and lyophilized to give HBOCoA 
(7) as a white powder (17 mg, 50.8% yield based on UV absorbance, HPLC: tR = 15.1 
min); 
1
H NMR (400MHz, D2O) δ: 8.56 (s, 1H), 8.28 (s, 1H), 6.20 (d, 2H, J = 8.0 Hz), 
4.62 (m, 1H), 4.28 - 4.23 (m, 3H), 4.21 (t, 2H, J = 8.0 Hz), 4.03 (s, 1H), 3.86 (d, 1H, J 
= 8.0 Hz), 3.60 (d, 1H, J = 8.0 Hz), 3.53 - 3.46 (m, 4H), 2.64 - 2.55 (m, 2H), 2.50 (t, 
2H, J = 8.0 Hz), 1.26 (d, 3H, J = 4.0 Hz), 0.91 (s, 3H), 0.78 (s, 3H); 
13
C NMR (100 
MHz, D2O) δ: 174.84, 174.26, 174.03, 155.64, 152.93, 149.43, 140.04, 118.76, 86.72, 
83.68, 74.30, 74.01, 72.02, 65.65, 64.71, 63.56, 43.27, 38.41, 35.60, 35.48, 22.15, 
20.98, 18.33; 
31
P NMR (161 MHz, D2O) δ: 2.13 (s, 1P), −11.31 (d, 1P, J = 19.3 Hz), 
−11.88 (d, 1P, J = 19.3 Hz); HRMS: calc. for C25H41N7O19P3
−
 [M−H]−: 836.1676, 
found: 836.1710. 
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(R)-tert-butyl-3-(benzyloxy)butanoate (8). To a solution of (R)-3-(benzyloxy) 
butanoic acid 4 (0.6 g, 3.08 mmol) in dry CH2Cl2 (20 mL) was added oxalyl chloride 
(1.17g, 9.24 mmol) at room temperature. After 10 min, a drop of DMF was added as 
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an initiator. The mixture was stirred for 2 hours and concentrated under reduced 
pressure. Then the yellow residue was diluted in CH2Cl2 (5 mL) and added slowly to a 
solution of 2-methylpropan-2-ol (0.27 g, 3.60 mmol) and pyridine (0.7 g, 9.24 mmol) 
in dry CH2Cl2 (20 mL) at 0 °C. The reaction was stirred overnight at room 
temperature. The reaction mixture was washed with brine, dried with Na2SO4 and 
concentrated under reduced pressure. The residue was purified by silica gel 
chromatography (hexane/EtOAc = 50/1 to 20/1) to afford the pure product 8 as a 
colorless oil (0.37 g, 48%).
1
H NMR (400 MHz, CDCl3) δ: 7.34 - 7.32 (m, 5H), 4.54 
(m, 2H), 3.98 (m, 1H), 2.44 (m, 2H), 1.45 (s, 9H), 1.25 (d, 3H, J = 8.0 Hz); 
13
C NMR 
(100 MHz, CDCl3) δ: 171.1, 138.8, 128.5, 127.9, 127.7, 80.6, 72.6, 71.1, 43.5, 28.3, 
20.0. 
 
(R)-tert-butyl 3-hydroxybutanoate (9). In the presence of H2 and Pd/C (20 mg), a 
solution of ester 8 (0.15 g, 0.6 mmol) in MeOH (5 mL) was vigorously stirred 
overnight at room temperature. Pd/C was removed via filtration and the filtrate was 
concentrated under reduced pressure to afford the product 9 (94 mg, 98%) as a 
colorless oil which was used in the next step without further purification. 
1
H NMR 
(400 MHz, CDCl3) δ: 4.13 (m, 1H), 3.22 (d, 1H, J = 4.0 Hz), 2.34 (m, 2H), 1.45 (s, 
9H), 1.19 (d, 3H, J = 8.0 Hz); 
13
C NMR (100 MHz, CDCl3) δ: 172.7, 81.5, 64.5, 43.9, 
28.3, 22.5. 
 
(R)-((R)-4-tert-butoxy-4-oxobutan-2-yl) 3-(benzyloxy)butanoate (10). To a 
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solution of acid 4 in dry CH2Cl2 (0.18g, 0.93 mmol) was added oxalyl chloride (0.37 
g, 1.48 mmol) at room temperature. After 10 min, a drop of DMF was added as an 
initiator. The mixture was stirred for 2 h and concentrated under reduced pressure. 
Then the yellow residue was diluted in dry CH2Cl2 (5 mL) added slowly to a solution 
of hydroxyl 9 (0.16 g, 1.0 mmol) and pyridine (250 mg, 3.16 mmol) in dry CH2Cl2 
(20 mL) at 0 °C. The reaction was stirred overnight at room temperature. The organic 
solution was washed with brine, dried with Na2SO4 and concentrated under reduced 
pressure. The residue was purified by silica gel chromatography (hexane/EtOAc = 
30/1 to 10/1) to afford the pure product 10 as a colorless oil (0.18 g, 57%). 
1
H NMR 
(400 MHz, CDCl3) δ: 7.33 - 7.27 (m, 5H), 5.27 (m, 1H), 4.52 (m, 2H), 3.99 (m, 1H), 
2.66 - 2.37 (m, 4H), 1.42 (s, 9H), 1.28 - 1.25 (m, 6H); 
13
C NMR (100 MHz, CDCl3) δ: 
170.7, 169.6, 138.7, 128.5, 127.8, 127.7, 81.07, 72.1, 71.0, 67.9, 42.4, 42.3, 28.25, 
20.1, 20.0. 
 
(R)-3-((R)-3-(benzyloxy)butanoyloxy)butanoic acid (11). To a solution of ester 10 
(0.16 g, 0.48 mmol) in CH2Cl2 (25 mL) was added trifluoro acetic acid (TFA) (2.7 g, 
24 mmol) at room temperature. TLC plates were used to check the progress of 
reaction. After 20 min, the reaction mixture was washed with brine, dried with 
Na2SO4 and concentrated under reduced pressure. The residue was purified by silica 
gel chromatography (hexane/EtOAc = 5/1 to 1/1) to afford the pure product 11 as a 
colorless oil (0.13 g, 98%). 
1
H NMR (400 MHz, CDCl3) δ: 7.33 - 7.26 (m, 5H), 5.27 
(m, 1H), 4.53 (m, 2H), 3.99 (m, 1H), 2.71 - 2.39 (m, 4H), 1.30 (d, 3H, J = 8.0 Hz), 
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1.25 (d, 3H, J = 8.0 Hz). 
13
C NMR (100 MHz, CDCl3) δ: 170.8, 138.6, 128.5, 127.8, 
127.7, 72.2, 71.0, 67.3, 42.3, 40.5, 20.0. 
 
(2R)-4-(2-(3-((4R)-2-(4-methoxyphenyl)-5,5-dimethyl-1,3-dioxane-4-carboxamido) 
propanamido) ethoxy)-4-oxobutan-2-yl (3R)-3-(benzyloxy)butanoate (12). To a 
solution of acid 11 (0.13 g, 0.48 mmol) in dry CH2Cl2 (20 mL) was added oxalyl 
chloride (0.12 g, 0.96 mmol) at room temperature. After 10 min, a drop of DMF was 
added to initiate the reaction. The mixture was stirred for 2 hr and then concentrated 
under reduced pressure. The residue was diluted in dry CH2Cl2 (5 mL) and added to a 
solution of alcohol 2 (0.21 g, 0.55 mmol) and pyridine (0.11 g, 1.40 mmol) in dry 
CH2Cl2 (20 mL) at 0 °C. The reaction was stirred overnight at room temperature. The 
reaction mixture was washed with brine, dried with Na2SO4 and concentrated under 
reduced pressure. The residue was purified by silica gel chromatography 
(CH2Cl2/MeOH = 100/1 to 20/1) to give the pure compound 12 as a white solid (0.28 
g, 90.8%). 
1
H NMR (400 MHz, CDCl3) δ: 7.43 (d, 2H, J = 8.0 Hz), 7.32 - 7.27 (m, 
5H), 7.06 (t, 1H, J = 4.0 Hz), 6.92 (d, 2H, J = 12.0 Hz), 6.30 (t, 1H, J = 4.0 Hz), 5.45 
(s, 1H), 5.34 (m, 1H), 4.56 (d, 1H, J = 12.0 Hz), 4.47 (d, 1H, J = 12.0 Hz), 4.09 (m, 
1H), 4.07 (s, 1H), 4.02 - 3.98 (m, 2H), 3.82 (s, 3H), 3.68 (dd, 2H, J = 24.0, 12.0 Hz), 
3.52 (m, 2H), 3.34 (m, 2H), 2.61 - 2.51 (m, 3H), 2.45 - 2.39 (m, 3H), 1.27 (d, 3H, J = 
8.0 Hz), 1.26 (d, 3H, J = 8.0 Hz), 1.10 (s, 3H), 1.09 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ: 171.00, 170.47, 169.74, 169.02, 159.85, 138.03, 129.89, 128.05, 127.40, 
127.32, 127.25, 113.37, 100.89, 83.46, 78.04, 71.64, 70.48, 67.09, 63.00, 54.97, 41.79, 
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40.55, 37.95, 35.18, 34.59, 32.72, 21.58, 19.77, 19.39, 18.8. 
 
(R)-4-(2-(3-((R)-2,4-dihydroxy-3,3-dimethylbutanamido)propanamido)ethoxy)-4-
oxobutan-2-yl (R)- 3-hydroxybutanoate (13). The reaction and silica gel 
chromatography were performed in the same way as 6 using ester 12 (0.12 g, 0.19 
mmol) to yield the pure product 13 as a colorless oil (0.07 g, 92.0%). 
1
H NMR (400 
MHz, CDCl3) δ: 7.43 (t, 1H, J = 4.0 Hz), 6.89 (t, 1H, J = 4.0 Hz), 5.36 (m, 1H), 4.36 
(d, 1H, J = 8.0 Hz), 4.21 (m, 1H), 4.19 - 4.15 (m, 2H), 3.98 (d, 1H, J = 4.0 Hz), 3.82 
(t, 1H, J = 8.0 Hz), 3.69 (d, 1H, J = 4.0 Hz), 3.57 - 3.52 (m, 2H), 3.49 - 3.41 (m, 4H), 
2.58 (m, 2H), 2.46 (t, 2H, J = 8.0 Hz), 2.42 (m, 2H), 1.31 (d, 3H, J = 4.0 Hz), 1.23 (d, 
3H, J = 8.0 Hz), 0.99 (s, 3H), 0.91 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ: 174.08, 
171.97, 171.57, 170.33, 76.82, 70.27, 67.37, 64.28, 63.14, 43.54, 40.75, 39.10, 38.38, 
35.47, 35.25, 22.80, 20.93, 20.41, 19.93. 
 
Enzymatic Synthesis of (HB)2OCoA (14). The reaction and HPLC were performed 
in the same way as HBOCoA (7) using precursor 13 to give the product (HB)2OCoA 
(14) (18 mg, 48.7% yield based on UV absorbance, tR = 26.4 min) as a white solid. 
1
H 
NMR (400 MHz, D2O) δ: 8.54, (s, 1H), 8.26 (d, 1H, J = 4.0 Hz), 6.18 (d, 1H, J = 8.0 
Hz), 5.27 (dq, 2H, J = 12.0, 4.0 Hz), 4.87 (q, 1H, J = 4.0 Hz), 4.61 (m, 1H), 4.27 (m, 
2H), 4.21 (m, 1H), 4.16 (t, 2H, J = 4.0 Hz) 4.02 (s, 1H), 3.86 (d, 1H, J = 8.0 Hz), 3.59 
(d, 1H, J = 8.0 Hz), 3.48 (q, 2H, J = 8.0 Hz), 3.44 (t, 2H, J = 8.0 Hz), 2.71 (d, 2H, J = 
8.0 Hz), 2.56 - 2.45 (m, 4H), 1.30 (d, 3H, J = 4.0 Hz), 1.22 (d, 3H, J = 4.0 Hz), 0.91 (s, 
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3H), 0.77 (s, 3H); 
13
C NMR (100 MHz, D2O) δ: 174.86, 174.21, 173.35, 172.98, 
155.21, 152.39, 149.31, 140.14, 118.69, 86.67, 83.59, 83.54, 74.28, 74.23, 74.19, 
73.94, 73.89, 72.08, 72.02, 68.79, 65.51, 64.78, 64.65, 63.71, 43.58, 40.37, 38.51, 
38.43, 38.34, 35.58, 35.47, 22.08, 20.98, 19.11, 18.30; 
31
P NMR (161 MHz, D2O) δ: 
0.51 (s, 1P), - 10.71 (d, 1P, J = 25.8 Hz), - 11.36 (d, 1P, J = 24.2 Hz); HRMS: calc. 
for C29H47N7O21P3
-
 [M−H]-: 922.2043, found: 922.2076. 
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(R)-((R)-4-tert-butoxy-4-oxobutan-2-yl) 3-((R)-3-(benzyloxy)butanoyloxy) butane 
ate (15). To a solution of acid 11 (0.9 g, 3.2 mmol) in CH2Cl2 (15 mL) was added 
oxalyl chloride (0.81 g, 6.4 mmol) at room temperature. After 10 min, a drop of DMF 
was added as an initiator of reaction. The reaction was stirred for 2 h and concentrated 
under reduced pressure. Then the yellow residue was diluted in CH2Cl2 (5 mL) added 
slowly to a solution of (R)-tert-butyl 3-hydroxybutanoate 9 (0.56 g, 3.5 mmol) and 
pyridine (0.77 g, 9.6 mmol) in dry CH2Cl2 (15 mL) at 0 °C. The reaction was stirred 
overnight at room temperature. The reaction mixture was washed with brine, dried 
with Na2SO4 and concentrated under reduced pressure. Further purification was 
accomplished with silica gel chromatography (hexane/EtOAc = 10/1 to 5/1) to give 
the pure product 15 (1.16 g, 83%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 
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7.33 - 7.27 (m, 5H), 5.26 (m, 2H), 4.52 (m, 2H), 3.98 (m, 1H), 2.63 - 2.42 (m, 6H), 
1.43 (s, 9H), 1.28 - 1.19 (m, 9H); 
13
C NMR (100 MHz, CDCl3) δ: 170.7, 169.5, 169.4, 
138.7, 128.5, 127.8, 127.7, 81.1, 72.1, 71.0, 68.1, 76.5, 42.3, 42.2, 41.1, 28.2, 20.1, 
20.0, 19.9. 
 
(R)-3-((R)-3-((R)-3-(benzyloxy)butanoyloxy)butanoyloxy)butanoic acid (16). To a 
solution of ester 15 (0.5 g, 1.18 mmol) in CH2Cl2 (10 mL) was added TFA (0.67 g, 
5.9 mmol) at room temperature. The progress of the reaction was checked by TLC. 
After 20 min, the reaction mixture was washed with brine, dried with Na2SO4 and 
concentrated under reduced pressure. Further purification was accomplished with 
silica gel chromatography (CH2Cl2/MeOH = 100/1 to 20/1) to afford the pure product 
16 (0.41 g, 94%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 7.33 (m, 5H), 5.30 
(m, 2H), 4.56 (m, 2H), 4.13 - 4.03 (m, 1H), 2.73 - 2.04 (m, 6H), 1.28 - 1.23 (m, 9H); 
13
C NMR (100 MHz, CDCl3) δ: 174.6, 170.7, 169.7, 138.2, 128.5, 128.0, 127.8, 72.3, 
71.2, 68.0, 67.8, 42.1, 41.3, 40.7, 20.1, 20.0, 19.9. 
 
(12R,16R)-1-((4R)-2-(4-methoxyphenyl)-5,5-dimethyl-1,3-dioxan-4-yl)-12-methyl
-1,5,10,14-tetraoxo- 9,13-dioxa-2,6-diazaheptadecan-16-yl (3R)-3-(benzyloxy) 
butanoate (17). The reaction and silica gel chromatography were performed in the 
same way as 12 using acid 16 (0.30 g, 0.82 mmol) and alcohol 2 (0.32 g, 0.84 mmol) 
to yield the product 17 as a white solid (0.49 g, 82.0%). 
1
H NMR (400 MHz, CDCl3) 
δ: 7.43 (d, 2H, J = 8.0 Hz), 7.32 - 7.27 (m, 5H), 7.07 (t, 1H, J = 4.0 Hz), 6.92 (d, 2H, 
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J = 8.0 Hz), 6.38 (t, 1H, J = 4.0 Hz), 5.46 (s, 1H), 5.32 (m, 1H), 5.25 (q, 1H, J = 8.0 
Hz), 4.56 (d, 1H, J = 12.0 Hz), 4.49 (d, 1H, J = 12.0 Hz), 4.11 (m, 2H), 4.07 (s, 1H), 
3.99 (q, 1H, J = 8.0 Hz), 3.81 (s, 3H), 3.68 (q, 2H, J = 12.0 Hz), 3.57 - 3.52 (m, 2H), 
3.50 - 3.44 (m, 2H), 2.64 - 2.55 (m, 3H), 2.51 - 2.38 (m, 5H), 1.27 (d, 3H, J = 4.0 Hz), 
1.25 (d, 3H, J = 4.0 Hz), 1.24 (d, 3H, J = 4.0 Hz), 1.10 (s, 3H), 1.09 (s, 3H); 
13
C NMR 
(100 MHz, CDCl3) δ: 171.22, 170.62, 170.00, 169.64, 169.37, 160.17, 138.42, 130.14, 
128.33, 127.62, 127.56, 127.50, 113.70, 101.25, 83.80, 78.44, 71.86, 70.77, 67.69, 
67.30, 63.51, 55.32, 42.07, 40.98, 40.89, 38.35, 35.66, 34.83, 33.06, 21.86, 20.07, 
19.84, 19.79, 19.14. 
 
(3R,15R,19R)-1,3-dihydroxy-2,2,15-trimethyl-4,8,13,17-tetraoxo-12,16-dioxa-5,9-
diazaicosan-19-yl (R)-3-hydroxybutanoate (18). The reaction and silica gel 
chromatography were performed in the same way as 6 using ester 17 (0.15 g, 0.20 
mmol) to yield the pure product 18 as a colorless oil (0.10 g, 96.1%). 
1
H NMR (400 
MHz, CDCl3) δ: 7.47 (t, 1H, J = 4.0 Hz), 6.92 (t, 1H, J = 4.0 Hz), 5.28 (m, 2H), 4.49 
(d, 1H, J = 4.0 Hz), 4.18 (nonet, 1H, J = 8.0 Hz), 4.16 - 4.13 (m, 2H), 3.96 (d, 1H, J = 
4.0 Hz), 3.67 (br, 1H), 3.54 (q, 2H, J = 4.0 Hz), 3.48 - 3.40 (m, 4H), 2.63 - 2.57 (m, 
2H), 2.52 (dd, 2H, J = 12.0, 4.0 Hz), 2.45 (t, 2H, J = 8.0 Hz), 2.40 (t, 2H, J = 4.0 Hz), 
1.29 (d, 3H, J = 4.0 Hz), 1.28 (d, 3H, J = 4.0 Hz), 1.21 (d, 3H, J = 4.0 Hz), 0.97 (s, 
3H), 0.89 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ: 174.13, 172.05, 171.81, 170.31, 
170.06, 77.51, 70.62, 67.93, 67.53, 64.40, 63.37, 43.54, 40.90, 39.29, 38.47, 35.65, 
35.32, 22.77, 21.27, 20.50, 20.08, 19.95. 
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Enzymatic Synthesis of (HB)3OCoA (19). The reaction and HPLC were performed 
in the same way as 7 using precursor 18 to give the product (HB)3OCoA (19) (19 mg, 
47.1% yield based on UV absorbance, tR = 36.5 min. 
1
H NMR (400 MHz, D2O) δ: 
8.57 (s, 1H), 8.26 (s, 1H), 6.17 (d, 1H, J = 4.0 Hz), 5.26 (dq, 2H, J = 12.0, 4.0 Hz), 
4.87 (m, 1H), 4.62 (m, 1H), 4.28 (m, 2H), 4.22 (m, 1H), 4.17 (t, 2H, J = 4.0 Hz) 4.03 
(s, 1H), 3.86 (d, 1H, J = 8.0 Hz), 3.60 (d, 1H, J = 8.0 Hz), 3.49 (m, 2H), 3.45 (t, 1H, J 
= 4.0 Hz), 2.74 - 2.66 (m, 4H), 2.54 - 2.47 (m, 4H), 1.27 (d, 6H, J = 4.0 Hz), 1.24 (d, 
3H, J = 8.0 Hz), 0.92 (s, 3H), 0.78 (s, 3H); 
13
C NMR (100 MHz, D2O) δ: 174.99, 
174.31, 173.40, 173.01, 172.42, 155.32, 152.48, 140.38, 86.89, 83.71, 74.43, 74.36, 
74.12, 72.22, 69.18, 68.85, 65.66, 64.74, 63.85, 43.72, 40.80, 40.43, 38.59, 38.50, 
35.74, 35.64, 22.28, 21.15, 19.25, 19.22, 18.47; 
31
P NMR (161 MHz, D2O) δ: 0.85 (s, 
1P), −10.06 (d, 1P, J = 17.7 Hz), −10.66 (d, 1P, J = 17.7 Hz); HRMS: calc. for 
C33H53N7O23P3
−
 [M−H]−: 1008.2411, found: 1008.2398. 
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(S)-4-hydroxy-dihydrofuran-2(3H)-one (21). To a solution of (S)-dimethyl 
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2-hydroxysuccinate (38.8 g, 0.24 mol) in 500 mL of dry THF was added slowly 
borane-dimethylsulfide complex (244 mL, 0.244 mol) for 10 min and the mixture was 
stirred at room temperature for 50 min. The reaction was cooled to 0 °C. NaBH4 (0.4 
g, 12 mmol) was added and the mixture was stirred for 30 min. The reaction was 
warmed to room temperature again and quenched by slow addition of methanol (154 
mL). When no air babble formed in the reaction, all solvents were removed under 
reduced pressure. The crude product 20 was used in the next step without further 
purification. To a solution of compound 20 in dry CH2Cl2 (300 mL) was added 
trifluoroacetic acid (6 mL). The reaction was stirred overnight at room temperature. 
TLC plate was used to check the progress of the reaction. The solvent was removed 
under reduced pressure and residue was purified by silica gel chromatography 
(hexane/EtOAc = 1/1 to 1/3) to afford the pure product 21 (21.5 g, 87%) as a colorless 
oil. 
1
H NMR (400 MHz, CDCl3) δ: 4.69 (s, 1H), 4.44 - 4.28 (m, 2H), 2.78 - 2.50 (m, 
2H), 2.61 (s, 1H). 
 
(S)-ethyl 3-hydroxy-4-iodobutanoate (22). To a solution of 21 (15.0 g, 0.148 mol) 
and absolute EtOH (26 mL, 0.444 mmol) in dry CH2Cl2 (500 mL) was added slowly 
Me3SiI (30 mL, 0.22 mmol) within 1 h. The color of the reaction changed to a dark 
brown. The reaction was stirred overnight at room temperature. All solvents were 
removed under a reduced pressure and the brown residue was dissolved again in ether 
(500 mL). The organic layer was washed with 5% aqueous Na2S2O3 solution (3 x 10 
mL), dried with Na2SO4, and concentrated under reduced pressure. The residue was 
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purified by gel silica chromatography (hexane/EtOAc = 5/1 to 3/1) to afford the pure 
product 22 as a pale yellow oil (37.2 g, 95%). 
1
H NMR (400 MHz, CDCl3) δ: 4.18 (q, 
2H, J = 8.0 Hz,), 4.03 - 3.96 (m, 1H), 3.32 (m, 2H), 3.18 (d, 1H, J = 4.0 Hz), 2.70 - 
2.57 (m, 2H), 1.28 (t, 3H, J = 8.0 Hz). 
 
(S)-ethyl 2-(oxiran-2-yl)acetate (23). A solution of compound 22 (15.0 g, 58.2 mmol) 
and Ag2O (16.2 g, 69.6 mmol) in DME (100 mL) was heated to reflux for 4 hr. After 
filtration, a volume of filtrate was concentrated down to 25 mL under reduced 
pressure. Further concentration may lead to a loss of the product. The concentrated 
solution was purified by gel silica chromatography (hexane/ether = 5/1 to 4/1) to 
afford the pure epoxide 23 (6.95 g, 92%) as a colorless oil. 
1
H NMR (400 MHz, 
CDCl3) δ: 4.18(q, 2H, J = 8.0 Hz), 3.30 - 3.28 (m, 1H), 2.83 (d, 1H, J = 4.0 Hz), 2.57 
- 2.56 (m, 3H), 1.28(t, 3H, J = 8.0 Hz). 
 
(R)-ethyl 3-hydroxypentanoate (24). To a suspension of copper bromide dimethyl 
sulfide complex (1.89 g, 9.21 mmol) in mixed solvents of dry THF (60 mL) and dry 
ether (120 mL) was added at -60 °C a solution of methylmagnesium bromide (6.14 
mL, 18.4 mmol) in ether. The reaction temperature increased from -60 to -30 
o
C and 
the reaction was stirred vigorously for 1 h. A black suspension was given. Then, 
epoxide 23 (1.0 g, 7.68 mmol) was added and the mixture was stirred at -30 °C. TLC 
plates were used to monitor the progress of the reaction. After 4 hr, the reaction was 
quenched by addition of an aqueous solution of saturated NH4Cl and a deep blue 
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aqueous solution was given. The organic layer was washed with saturated NH4Cl, 
dried with Na2SO4 and concentrated under reduced pressure. The residue was purified 
by gel silica chromatography (hexane/EtOAc = 10/1 to 5/1) to afford the pure product 
24 (751 mg, 67%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 4.17 (q, 2H, J = 
8.0 Hz), 3.96 - 3.90 (m, 1H), 3.00 (br, 1H), 2.53 - 2.40 (m, 2H), 1.52 (m, 2H), 1.28 (t, 
3H, J = 4.0 Hz), 0.96 (t, 3H, J = 8.0 Hz). 
 
(R)-ethyl 3-(tert-butyldimethylsilyloxy)pentanoate (25). To a solution of 
compound 24 (680 mg, 4.65 mmol) and imidazole (633 mg, 9.31 mmol) in dry DMF 
(5 mL) was added TBDMSCl (1.05 g, 6.97 mmol). The mixture was stirred overnight 
at room temperature. Then the reaction was quenched by addition of H2O and 
extracted with ether. The organic layer was washed with brine, dried with Na2SO4 and 
concentrated under reduced pressure. The residue was purified by gel silica 
chromatography (hexane/EtOAc = 100/1 to 50/1) to afford the pure product 25 (1.14 
g, 94%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 4.15 - 4.05 (m, 3H), 2.46 - 
2.37 (m, 2H), 1.51 (m, 2H), 1.26 (t, 3H, J = 4.0 Hz), 0.88 (t, 3H, J = 4.0 Hz), 0.86 (s, 
9H), 0.06 (s, 3H), 0.03 (s, 3H). 
 
(R)-3-(tert-butyldimethylsilyloxy)pentanoic acid (26). To a solution of ester 25 (1.0 
g, 3.84 mmol) in MeOH (10 mL) was added NaOH solution (10 mL, 19.2 mmol). The 
reaction was stirred at 50 °C for 3 hr and MeOH was removed under reduced pressure. 
The pH value of residue was adjusted to 4.0 with dilute hydrochloric acid (1 M) and a 
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white suspension was given. The suspension was extracted with ether. The combined 
organic solution was washed with brine, dried with Na2SO4 and concentrated under 
reduced pressure to afford the pure product 26 (780 mg, 88%) as a colorless oil which 
was used in the next step without further purification. 
1
H NMR (400 MHz, CDCl3) δ: 
4.10 - 4.05 (m, 1H), 2.51 - 2.49 (m, 2H), 1.58 - 1.53 (m, 2H), 0.91 (t, 3H, J = 6.0 Hz), 
0.89 (s, 9H), 0.09 (s, 3H), 0.07 (s, 3H). 
 
(R)-S-phenyl 3-(tert-butyldimethylsilyloxy)pentanethioate (27). To a solution of 
acid 26 (650 mg, 2.80 mmol), DCC (692 mg, 3.36 mmol) and catalytic amount of 
DMAP (10 mg) in dry CH2Cl2 (15 mL) was added freshly distilled benzenethiol (338 
mg, 3.08 mmol). The reaction was stirred overnight at room temperature. After 
filtration, the filtrate was concentrated under reduced pressure. The residue was 
purified by gel silica chromatography (hexane/EtOAc = 50/1 to 20/1) to afford the 
pure product 27 (624 mg, 69%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 7.40 
(s, 5H), 4.18 - 4.12 (m, 1H), 2.78 - 2.71 (m, 2H), 1.58 - 1.53 (m, 2H), 0.90 (t, 3H, J = 
6.0 Hz), 0.89 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H). 
 
(R)-S-phenyl 3-hydroxypentanethioate (28). The removal of TBDMS-protecting 
group in thiolester 27 (510 mg, 1.57 mmol) was readily accomplished with 5% HF in 
MeCN (7 mL). The mixture was stirred at room temperature. TLC plates were used to 
check the progress of the reaction. After 4 hr, saturated NaHCO3 was added and the 
mixture was extracted with ether. The combined organic solution was washed with 
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brine, dried with Na2SO4 and concentrated under reduced pressure. The residue was 
purified by gel silica chromatography (hexane/EtOAc = 5/1 to 3/1) to afford the pure 
product 28 (303 mg, 92%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 7.43 (s, 
5H), 4.06 - 3.99 (m, 1H), 2.90 - 2.77 (m, 2H), 2.66 (d, 1H, J = 4.0 Hz), 1.59 - 1.54 (m, 
2H), 0.89 (t, 3H, J = 6.0 Hz). 
13
C NMR (100 MHz, CDCl3) δ: 198.13, 134.75, 129.88, 
129.11, 127.43, 70.09, 50.16, 29.69, 10.09. 
 
Synthesis of CoA analog (29). To a solution of CoA (80 mg, 0.1 mmol) in KPi buffer 
(3 mL, 50mM, pH = 9.5) was added (R)-S-phenyl 3-hydroxypentanethioate 28 (0.5 
mmol) which was dissolved in 0.3 mL of acetonitrile. The reaction was saturated with 
argon and stirred vigorously overnight at room temperature. The analytic HPLC was 
used to check the progress of the reaction. After 24 hr, excess 28 and byproduct 
benzenethiol were extracted with ether. The pH value of the aqueous solution was 
adjusted to 4 - 5 by addition of HCl (1 M). The solution was loaded onto a 
semi-preparative HPLC column (Luna C18-2, 5 μm, 10 mm × 250 mm) that was 
eluted at 3.00 mL/min using a linear gradient from 5 to 95% methanol in 10.0 mM 
ammonium acetate (pH = 4.00) over 70 min. The fractions containing the product 
were pooled, concentrated, and lyophilized to give CoA analog 29 a white powder (62 
mg, 71% yield based on UV absorbance, HPLC: tR = 22.0 min). NMR (400 MHz, 
D2O) δ: 8.65 (s, 1H), 8.41 (s, 1H), 6.18 (d, 1H, J = 4.0 Hz), 4.58 (s, 1H), 4.25 (s, 2H), 
4.01 (s, 1H), 3.96 (m, 1H), 3.84 (m, 1H), 3.58 (m, 1H), 3.43 (t, 2H, J = 8.0 Hz), 3.32(t, 
2H, J = 8.0 Hz), 2.99 (m, 2H), 2.82 - 2.67 (m, 2H), 2.41 (t, 2H, J = 8.0 Hz), 1.49 - 
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1.42 (m, 2H), 0.92 (s, 3H), 0.86 (t, 3H, J = 8.0 Hz), 0.79 (s, 3H). 
31
P NMR (161 MHz, 
D2O) δ: 1.55 (s, 1H), -9.77 (d, 1H, J = 20.9 Hz), -10.34 (d, 1H, J = 20.9 Hz). 
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(R)-ethyl 3-hydroxyhexanoate (30). The reaction and silica gel chromatography 
were performed in the same way as 24 using epoxide 23 (1.0 g, 7.68 mmol) and 
ethylmagnesium bromide solution (18.4 mL, 18.4 mmol) to afford the pure product 30 
(798 mg, 65%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 4.16 (q, 2H, J = 8.0 
Hz), 4.04 - 3.99 (m, 1H), 2.52 - 2.36 (m, 2H), 1.55 - 1.36 (m, 4H), 1.27 (t, 3H, J = 6.0 
Hz), 0.93 (t, 3H, J = 6.0 Hz). 
 
(R)-ethyl 3-(tert-butyldimethylsilyloxy)hexanoate (31). The reaction and silica gel 
chromatography were performed in the same way as 25 using alcohol 30 (650 mg, 4.1 
mmol) to afford the pure product 31 (1.05 g, 94%) as a colorless oil. 
1
H NMR (400 
MHz, CDCl3) δ: 4.14 - 4.08 (m, 3H), 2.43 - 2.40 (m, 2H), 1.55 - 1.37 (m, 4H), 1.26 (t, 
3H, J = 4.0 Hz), 0.88 (t, 3H, J = 4.0 Hz), 0.86 (s, 9H), 0.06 (s, 3H), 0.03 (s, 3H). 
 
(R)-3-(tert-butyldimethylsilyloxy)hexanoic acid (32). The reaction was performed 
in the same way as 26 using TBDMS-protected ester 31 (920 mg, 3.35 mmol) to 
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afford the pure product 32 (750 mg, 91%) as a colorless oil. 
1
H NMR (400 MHz, 
CDCl3) δ: 4.12 - 4.08 (m, 1H), 2.53 - 2.46 (m, 2H), 1.50 (m, 2H), 1.34 (m, 2H), 0.90 
(t, 3H, J = 4.0 Hz), 0.86 (s, 9H), 0.10 (s, 3H), 0.08 (s, 3H). 
 
(R)-S-phenyl 3-(tert-butyldimethylsilyloxy)hexanethioate (33). The reaction and 
silica gel chromatography were performed in the same way as 27 using 
TBDMS-protected acid 32 (650 mg, 2.64 mmol) to afford the pure product 33 (642 
mg, 72%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 7.40 (s, 5H), 4.21 - 4.16 
(m, 1H), 2.84 - 2.70 (m, 2H), 1.50 (m, 2H), 1.35 (m, 2H), 0.90 (t, 3H, J = 4.0 Hz), 
0.86 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H). 
 
(R)-S-phenyl 3-hydroxyhexanethioate (34). The reaction and silica gel 
chromatography were performed in the same way as 28 using thiolester 33 (520 mg, 
1.53 mmol) to afford the pure product 34 (315 mg, 94%) as a colorless oil. 
1
H NMR 
(400 MHz, CDCl3) δ: 7.43 (s, 5H), 4.12 - 4.08 (m, 1H), 2.89 - 2.78 (m, 2H), 2.62 (d, 
1H, J = 4.0 Hz), 1.52 - 1.38 (m, 4H), 0.94 (t, 3H, J = 8.0 Hz). 
13
C NMR (100 MHz, 
CDCl3) δ: 197.62, 134.73, 129.79, 129.50, 127.65, 68.47, 50.85, 39.20, 18.96, 14.30. 
 
Synthsis of CoA analog (35). The reaction and purification were performed in the 
same way as 29 using (R)-S-phenyl 3-hydroxyhexanethioate 34 (0.8 mmol) and 
HSCoA (80 mg, 0.1 mmol) to afford the CoA analog 35 as a white solid (57 mg, 64% 
yield based on UV absorbance, HPLC: tR = 25.5 min). NMR (400 MHz, D2O) δ: 8.52 
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(s, 1H), 8.24 (s, 1H), 6.15 (d, 1H, J = 4.0 Hz), 4.56 (s, 1H), 4.21 (s, 1H), 4.03 (m, 1H), 
3.98 (s, 1H), 3.79 (m, 1H), 3.54 (m, 1H), 3.42 (t, 2H, J = 8.0 Hz), 3.30 (t, 2H, J = 8.0 
Hz), 2.97 (m, 2H), 2.76 - 2.65 (m, 2H), 2.39 (t, 2H, J = 8.0 Hz), 1.42 - 1.27 (m, 4H), 
0.86 (s, 3H), 0.84 (t, 3H, J = 8.0 Hz), 0.73 (s, 3H). 
31
P NMR (161 MHz, D2O) δ: 1.36 
(s, 1H), -9.72 (m, 1H), -10.26 (m, 1H). 
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(R)-ethyl 3-hydroxyoctanoate (36). The reaction and silica gel chromatography were 
performed in the same way as 24 using epoxide 23 (1.0 g, 7.68 mmol) and 
n-butyllithium solution (11.5 mL, 18.4 mmol) to afford the pure product 36 (808 mg, 
56%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 4.16 (q, 2H, J = 8.0 Hz), 4.01 
- 3.96 (m, 1H), 2.99 (d, 1H, J = 4.0 Hz), 2.51 - 2.39 (m, 2H), 1.48 - 1.24 (m, 12H), 
0.88 (t, 3H, J = 6.0 Hz). 
 
(R)-ethyl 3-(tert-butyldimethylsilyloxy)octanoate (37). The reaction and silica gel 
chromatography were performed in the same way as 25 using alcohol 36 (720 mg, 
3.83 mmol) to afford the pure product 37 (1.06 g, 92%) as a colorless oil. 
1
H NMR 
(400 MHz, CDCl3) δ: 4.14 - 4.08 (m, 3H), 2.43 - 2.41 (m, 2H), 1.52 - 1.24 (m, 11H), 
0.88 (t, 3H, J = 4.0 Hz), 0.85 (s, 9H), 0.06 (s, 3H), 0.03 (s, 3H). 
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(R)-3-(tert-butyldimethylsilyloxy)octanoic acid (38). The reaction was performed in 
the same way as 26 using protected ester 37 (920 mg, 3.05 mmol) to afford the pure 
product 38 (710 mg, 85%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 4.13 - 
4.06 (m, 1H), 2.56 - 2.47 (m, 2H), 1.52 - 1.24 (m, 8H), 0.88 (t, 3H, J = 4.0 Hz), 0.89 
(s, 9H), 0.10 (s, 3H), 0.09 (s, 3H). 
 
(R)-S-phenyl 3-(tert-butyldimethylsilyloxy)octane thioate (39). The reaction and 
silica gel chromatography were performed in the same way as 27 using TBDMS-acid 
38 (550 mg, 2.0 mmol) to afford the pure product 39 (361 mg, 66%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 7.40 (s, 5H), 4.22 - 4.16 (m, 1H), 2.84 - 2.70 (m, 2H), 
1.56 (m, 2H), 1.31 (m, 6H), 0.89 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H). 
13
C NMR (100 
MHz, CDCl3) δ: 196.00, 129.56, 134.58, 129.37, 129.29, 127.69, 127.37, 69.80, 51.54, 
37.77, 32.06, 26.09, 24.84, 22.84, 18.30, 14.26, -4.29, -4.49. 
 
(R)-S-phenyl 3-hydroxyoctane thioate (40). The reaction and silica gel 
chromatography were performed in the same way as 28 using TBDMS-thiolester 39 
(290 mg, 0.86 mmol) to afford the pure product 40 (197 mg, 91%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 7.43 (s, 5H), 4.13 - 4.08 (m, 1H), 2.89 - 2.76 (m, 2H), 
2.63 (d, 1H, J = 4.0 Hz), 1.56 - 1.29 (m, 8H), 0.89 (t, 3H, J = 6.0 Hz). 
13
C NMR (100 
MHz, CDCl3) δ: 198.36, 134.74, 129.91, 129.53, 127.32, 68.85, 50.45, 36.68, 31.92, 
25.35, 22.82, 14.27. 
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Synthesis of CoA analog (41). The reaction and purification were performed in the 
same way as 29 using (R)-S-phenyl 3-hydroxyoctane thioate 40 (0.7 mmol) and 
HSCoA (80 mg, 0.1 mmol) to afford the CoA analog 41 as a white solid (45 mg, 49% 
yield based on UV absorbance, HPLC: tR = 35.5 min). NMR (400 MHz, D2O) δ: 8.52 
(s, 1H), 8.22 (s, 1H), 6.14 (d, 1H, J = 4.0 Hz), 4.56 (s, 1H), 4.21 (s, 2H), 4.00 - 3.99 
(m, 2H), 3.80 (m, 1H), 3.54 (m, 1H), 3.42 (t, 2H, J = 8.0 Hz), 3.30 (t, 2H, J = 8.0 Hz), 
2.99 - 2.96 (m, 2H), 2.76 - 2.68 (m, 2H), 2.40 (t, 2H, J = 8.0 Hz), 1.42 - 1.19 (m, 8H), 
0.86 (s, 3H), 0.80 (t, 3H, J = 8.0 Hz), 0.73 (s, 3H). 
31
P NMR (161 MHz, D2O) δ: 1.58 
(s, 1H), -9.71 (m, 1H), -10.17 (m, 1H). 
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Scheme 3 - 7. Synthesis of CoA analog 47 
 
(R)-ethyl 3-hydroxy-4-phenyl butanoate (42). The reaction and silica gel 
chromatography were performed in the same way as 24 using epoxide 23 (1.0 g, 7.68 
mmol) and phenylmagnesium chloride solution (9.2 mL, 18.4 mmol) in THF to afford 
the pure product 42 (719 mg, 45%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 
7.33 - 7.22 (m, 5H), 4.28 - 4.25 (m, 1H), 4.15 (q, 2H, J = 8.0 Hz), 3.00 (d, 1H, J = 4.0 
Hz), 2.89 - 2.75 (m, 2H), 2.52 - 2.40 (m, 2H), 1.26 (t, 3H, J = 8.0 Hz). 
 
(R)-ethyl 3-(tert-butyldimethylsilyloxy)-4-phenyl butanoate (43). The reaction and 
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silica gel chromatography were performed in the same way as 25 using alcohol 42 
(620 mg, 2.98 mmol) to afford the pure product 43 (911 mg, 95%) as a white solid. 
1
H 
NMR (400 MHz, CDCl3) δ: 7.30 - 7.17 (m, 5H), 4.31 (q, 2H, J = 8.0 Hz), 4.11 - 4.06 
(m, 1H), 2.81 - 2.79 (m, 2H), 2.42 (d, 2H, J = 8.0 Hz), 1.25 (t, 3H, J = 8.0 Hz), 0.83 (s, 
9H), -0.02 (s, 3H), -0.14 (s, 3H). 
 
(R)-3-(tert-butyldimethylsilyloxy)-4-phenyl butanoic acid (44). The reaction was 
performed in the same way as 26 using TBDMS-protected ester 43 (800 mg, 2.48 
mmol) to afford the pure product 44 (650 mg, 89%) as a white solid. 
1
H NMR (400 
MHz, CDCl3) δ: 7.31 - 7.17 (m, 5H), 4.32 - 4.26 (m, 1H), 2.85 - 2.77 (m, 2H), 2.53 - 
2.44 (m, 2H), 0.85 (s, 9H), 0.01 (s, 3H), -0.11 (s, 3H). 
13
C NMR (100 MHz, CDCl3) δ: 
176.67, 137.92, 129.93, 128.65, 126.81, 70.95, 44.13, 41.74, 25.96, 18.18, 4.72, -4.89. 
 
(R)-S-phenyl 3-(tert-butyldimethylsilyloxy)-4-phenyl butanethioate (45). The 
reaction and silica gel chromatography were performed in the same way as 27 using 
TBDMS-acid 44 (500 mg, 1.70 mmol) to afford the pure product 45 (486 mg, 74%) as 
a white solid. 
1
H NMR (400 MHz, CDCl3) δ: 7.41 - 7.18 (m, 10H), 4.39 - 4.35 (m, 
1H), 2.84 - 2.70 (m, 4H), 0.87 (s, 9H), 0.00 (s, 3H), -0.13 (s, 3H). 
13
C NMR (100 
MHz, CDCl3) δ: 195.89, 138.16, 134.60, 130.04, 129.63, 129.41, 128.56, 128.02, 
126.69, 71.20, 50.79, 44.33, 26.09, 18.28, -4.69, -4.75. 
 
(R)-S-phenyl 3-hydroxy-4-phenyl butanethioate (46). The reaction and silica gel 
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chromatography were performed in the same way as 28 using thiolester 45 (360 mg, 
0.93 mmol) to afford the pure product 46 (238 mg, 94%) as a white solid. 
1
H NMR 
(400 MHz, CDCl3) δ: 7.44 - 7.22 (m, 10H), 4.38 - 4.31 (m, 1H), 2.91 - 2.63 (m, 4H), 
2.63 (d, 1H, J = 4.0 Hz). 
13
C NMR (100 MHz, CDCl3) δ: 197.78, 137.71, 134.79, 
129.95, 129.77, 129.77, 129.70, 129.59, 128.90, 127.38, 127.02, 69.75, 49.67, 43.19. 
 
Synthesis of CoA analog (47). The reaction and purification were performed in the 
same way as 29 using (R)-S-phenyl 3-hydroxy-4-phenyl butanethioate 46 (0.2 mmol) 
and HSCoA (40 mg, 0.05 mmol) to afford the CoA analog 47 as a white solid (20 mg, 
44% yield based on UV absorbance, HPLC: tR = 33.1 min). NMR (400 MHz, D2O) δ 
8.50 (s, 1H), 8.19 (s, 1H), 7.31 - 7.19 (m, 6H), 6.12 (d, 1H, J = 4.0 Hz), 4.56 (s, 1H), 
4.29 (m, 1H), 4.21 (s, 1H), 3.98 (s, 1H), 3.80 (m, 1H), 3.53 (m, 1H), 3.40 (t, 2H, J = 
4.0 Hz), 3.29 (d, 1H, J = 4.0 Hz), 2.99 - 2.94 (m, 2H), 2.76 (m, 3H), 2.38 (t, 2H, J = 
6.0 Hz), 0.85 (s, 3H), 0.71 (s, 3H). 
31
P NMR (161 MHz, D2O) δ: 2.63 (s, 1H), -9.62 
(m, 1H), -10.13 (m, 1H). 
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(R)-ethyl 3-hydroxyhex-5-enoate (48). The reaction and silica gel chromatography 
were performed in the same way as 24 using epoxide 23 (1.0 g, 7.68 mmol) and 
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vinylmagnesium bromide solution in THF (18.4 mL, 18.4 mmol) to afford the pure 
product 48 (655 mg, 54%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 5.87 - 
5.76 (m, 1H), 5.14 - 5.10 (m, 2H), 4.16 (q, 2H, J = 8.0 Hz), 4.10 - 4.05 (m, 1H), 2.98 
(d, 1H, J = 4 Hz), 2.52 - 2.22 (m, 2H), 2.30 - 2.22 (m, 2H), 1.26 (t, 3H, J = 8.0 Hz). 
 
(R)-ethyl 3-(tert-butyldimethylsilyloxy) hex-5-enoate (49). The reaction and silica 
gel chromatography were performed in the same way as 25 using alcohol 48 (540 mg, 
3.43 mmol) to afford the pure product 49 (850 mg, 91%) as a colorless oil. 
1
H NMR 
(400 MHz, CDCl3) δ: 5.85 - 5.75 (m, 1H), 5.08 - 5.04 (m, 2H), 4.23 - 4.07 (m, 3H), 
2.43 - 2.41 (m, 2H), 2.27 (t, 2H, J = 8.0 Hz), 0.86 (s, 9H), 0.07 (s, 3H), 0.04 (s, 3H). 
 
(R)-3-(tert-butyldimethylsilyloxy) hex-5-enoic acid (50). The reaction was 
performed in the same way as 26 using TBDMS-protected ester 49 (740 mg, 2.72 
mmol) to afford the pure product 50 (604 mg, 91%) as a colorless oil. 
1
H NMR (400 
MHz, CDCl3) δ: 5.83 - 5.73 (m, 1H), 5.12 - 5.07 (m, 2H), 4.21 - 4.15 (m, 1H), 2.57 - 
2.45 (m, 2H), 2.30 (t, 2H, J = 6.0 Hz), 0.88 (s, 9H), 0.10 (s, 3H), 0.08 (s, 3H). 
 
(R)-S-phenyl 3-(tert-butyldimethylsilyloxy) hex-5-ene thioate (51). The reaction 
and silica gel chromatography were performed in the same way as 27 using 
TBDMS-protected acid 50 (420 mg, 1.72 mmol) to afford the pure product 51 (440 
mg, 76%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 7.40 (s, 5H), 5.84 - 5.77 
(m, 1H), 5.12 - 5.08 (m, 2H), 4.30 - 4.24 (m, 1H), 2.82 - 2.72 (m, 2H), 2.32 - 2.28 (m, 
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2H), 0.89 (s, 9H), 0.07 (s, 3H), 0.05 (s, 3H). 
13
C NMR (100 MHz, CDCl3) δ: 195.94, 
134.58, 134.10, 129.60, 129.39, 128.10, 118.33, 69.25, 50.95, 42.33, 26.07, 18.31, 
-4.26, -4.60. 
 
(R)-S-phenyl 3-hydroxyhex-5-ene thioate (52). The reaction and silica gel 
chromatography were performed in the same way as 28 using TBDMS-protected 
thiolester 51 (280 mg, 0.83 mmol) to afford the pure product 52 (172 mg, 93%) as a 
colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 7.43 (s, 5H), 5.86 - 5.79 (m, 1H), 5.18 - 
5.14 (m, 2H), 4.20 - 4.15 (m, 1H), 2.91 - 2.78 (m, 2H), 2.68 (d, 1H, J = 4.0 Hz), 2.31 
(t, 2H, J = 8.0 Hz). 
13
C NMR (100 MHz, CDCl3) δ: 197.98, 135.82, 133.91, 129.93, 
129.54, 127. 27, 118.83, 68.02, 49.66, 41.14. 
 
Synthesis of CoA analog (53). The reaction and purification were performed in the 
same way as 29 using (R)-S-phenyl 3-hydroxyhex-5-ene thioate 52 (0.3 mmol) and 
HSCoA (40 mg, 0.05 mmol) to afford the CoA analog 53 as a white solid (23 mg, 53% 
yield based on UV absorbance, HPLC: tR = 23.2 min). NMR (400 MHz, D2O) δ: 8.52 
(s, 1H), 8.24 (s, 1H), 6.14 (d, 1H, J = 4.0 Hz), 5.82 – 5.75 (m, 1H), 5.13 - 5.09 (m, 
2H), 4.56 (s, 1H), 4.21 (s, 2H), 4.12 (m, 1H), 3.99 (s, 1H), 3.80 (m, 1H), 3.55 (m, 1H), 
3.42 (t, 2H, J = 8.0 Hz), 3.30 (t, 2H, J = 8.0 Hz), 2.99 (m, 2H), 2.82 - 2.66 (m, 2H), 
2.40 (t, 2H, J = 8.0 Hz), 2.25 - 2.21 (m, 2H), 0.86 (s, 3H), 0.73 (s, 3H). 
31
P NMR (161 
MHz, D2O) δ: 1.82 (s, 1H), -9.73 (m, 1H), -10.06 (m, 1H). 
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(R)-ethyl 3-hydroxy-6-(trimethylsilyl) hex-5-ynoate (54). To a solution of 
trimethylsilyl acetylene (1.28 mL, 9.21 mmol) in dry toluene (20 mL) at - 45 °C was 
added n-BuLi (3.68 mL, 9.21 mmol). After 10 min, the mixture was warmed to 0 °C 
and vigorously stirred for 1 h. Then, diethylaluminum chloride (9.21 mL, 9.21 mmol) 
at 0 °C was added and the mixture was stirred for 1 h. Epoxide 23 (1.0 g, 7.68 mmol) 
in toluene (5 mL) was added and the reaction was stirred at 0 
o
C. TLC plates were 
used to check the progress of the reaction. After 4 hr, the reaction was quenched by 
adding saturated NH4Cl dropwise. After filtration, the organic layer was washed with 
brine, dried with Na2SO4 and concentrated under reduced pressure. The residue was 
purified by silica gel chromatography (hexane/EtOAc = 50/ to 10/1) to afford the pure 
product 54 (822 mg, 47%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 4.21 - 
4.16 (m, 3H), 3.03 (d, 1H, J = 4.0 Hz), 2.68 - 2.65 (m, 1H), 2.56 - 2.45 (m, 3H), 1.28 
(t, 3H, J = 6.0 Hz), 0.15 (s, 9H). 
 
(R)-ethyl 3-(triisopropylsilyloxy)-6-(trimethylsilyl) hex-5-ynoate (55). To a 
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solution of alcohol 54 (710 mg, 3.11 mmol) and diisopropylethylamine (802 mg, 6.22 
mmol) in dry CH2Cl2 (20 mL) at 0 °C was added triisopropylsilyl 
trifluoromethanesulfonate (1.43 g, 4.66 mmol). The reaction was stirred for 3 hr at 
0 °C and was quenched with H2O. The organic layer was washed with brine, dried 
with Na2SO4 and concentrated under reduced pressure. The residue was purified by 
silica gel chromatography (hexane to hexane/EtOAc = 100/1) to afford the pure 
product 55 (931 mg, 78%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 4.43 - 
4.37 (m, 1H), 4.13 (t, 2H, J = 8.0 Hz), 2.73 - 2.68 (m, 1H), 2.58 - 2.50 (m, 3H), 1.24 
(q, 3H, J = 8.0 Hz), 1.09 - 1.05 (m, 21H), 0.13 (s, 9H). 
 
(R)-3-(triisopropylsilyloxy)hex-5-ynoic acid (56). To a solution of compound 55 
(850 mg, 2.21 mmol) in MeOH (10 mL) was added an aqueous solution of NaOH (10 
mL, 11.0 mmol). The reaction was stirred at 50 °C for 7 hr. Then, MeOH was 
removed under reduced pressure. The residue was acidified (pH = 4.0) with dilute 
HCl and extracted with ether. The combined organic layer was washed with brine, 
dried with Na2SO4 and concentrated under reduced pressure. The residue was purified 
by silica gel chromatography (hexane/EtOAc = 10/1 to 5/1) to afford the pure product 
56 (514 mg, 82%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 4.45 - 4.37 (m, 
1H), 2.83 - 2.64 (m, 2H), 2.53 - 2.51 (m, 2H), 2.04 (t, 1H, J = 4.0 Hz), 1.12 - 1.06 (m, 
21H). 
 
(R)-S-phenyl 3-(triisopropylsilyloxy)hex-5-yne thioate (57). The reaction and silica 
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gel chromatography were performed in the same way as 27 using TIPS-protected acid 
56 (440 mg, 1.55 mmol) to afford the pure product 57 (379 mg, 65%) as a colorless 
oil. 
1
H NMR (400 MHz, CDCl3) δ: 7.41 (s, 5H), 4.51 - 4.45 (m, 1H), 3.13 - 2.94 (m, 
2H), 2.50 (d, 2H, J = 4.0 Hz), 2.05 (t, 1H, J = 4.0 Hz), 10.7 (s, 21H). 
13
C NMR (100 
MHz, CDCl3) δ: 195.49, 134.63, 129.66, 129.41, 127.94, 80.42, 71.41, 68.18, 50.49, 
27.76, 18.35, 18.32, 12.67. 
 
(R)-S-phenyl 3-hydroxyhex-5-yne thioate (58). The reaction and silica gel 
chromatography were performed in the same way as 28 using thiolester 57 (310 mg, 
0.82 mmol) to afford the pure product 58 (164 mg, 91%) as a colorless oil. 
1
H NMR 
(400 MHz, CDCl3) δ: 7.43 (s, 5H), 4.31 - 4.25 (m, 1H), 3.08 - 2.84 (m, 2H), 2.59 (br, 
1H), 2.49 - 2.46 (m, 2H), 2.11 (t, 1H, J = 4.0 Hz). 
13
C NMR (100 MHz, CDCl3) δ: 
197.70, 134.75, 130.01, 129.58, 127.09, 79.89, 71.71, 67.07, 48.93, 26.55. 
 
Synthesis of CoA analog (59). The reaction and purification were performed in the 
same way as 29 using (R)-S-phenyl 3-hydroxyhex-5-yne thioate 58 (0.2 mmol) and 
HSCoA (40 mg, 0.05 mmol) to afford the CoA analog 59 as a white solid (24 mg, 56% 
yield based on UV absorbance, HPLC: tR = 20.2 min). NMR (400 MHz, D2O) δ: 8.53 
(s, 1H), 8.25 (s, 1H), 6.16 (d, 1H, J = 4.0 Hz), 4.58 (s, 1H), 4.22 (m, 4H), 3.99 (s, 1H), 
3.82 (m, 1H),  3.56 (m, 2H), 3.43 (t, 2H, J = 8.0 Hz), 3.32 (t, 2H, J = 8.0 Hz), 2.99 (t, 
2H, J = 8.0 Hz), 2.89 - 2.85 (m, 2H), 2.44 - 2.40 (m, 4H), 1.17 (t, 1H, J = 4.0 Hz), 
0.87 (s, 3H), 0.74 (s, 3H). 
31
P NMR (161 MHz, D2O) δ: 1.96 (s, 1H), -9.57 (m, 1H), 
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-10.10 (m, 1H). 
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(S)-ethyl 4-azido-3-hydroxy butanoate (60). A solution of sodium azide (1.52 g, 
233 mmol) and (S)-ethyl 3-hydroxy-4-iodobutanoate 22 (4.0 g, 15.6 mmol) in dry 
DMF (10 mL) was heated to 100 °C for 2 h. After cooling to room temperature, the 
solution was dissolved in ether (50 mL). The mixture was washed with brine, dried 
with Na2SO4 and concentrated under reduced pressure. The residue was purified by 
silica gel chromatography (hexane/EtOAc = 2/1) to afford the pure product 60 (2.6 g, 
95%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 4.19 (q, 2H, J = 6.0 Hz), 3.39 
- 3.31 (m, 2H), 3.21 (br, 1H), 2.55 - 2.53 (m, 2H), 1.28 (t, 3H, J = 8.0 Hz).  
 
(S)-ethyl 4-azido-3-(tert-butyldimethylsilyloxy) butanoate (61). The reaction and 
silica gel chromatography were performed in the same way as 25 using alcohol 60 
(2.2 g, 12.7 mmol) to afford the pure product 61 (3.17 g, 87%) as a colorless oil. 
1
H 
NMR (400 MHz, CDCl3) δ: 4.27 - 4.16 (m, 1H), 4.15 - 4.09 (t, 2H, J = 8.0 Hz), 3.38 - 
3.23 (m, 2H), 2.55 - 2.52 (m, 2H), 1.26 (q, 3H, J = 8.0 Hz), 0.88 (s, 9H), 0.12 (s, 3H), 
0.08 (s, 3H).  
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(S)-4-azido-3-(tert-butyldimethylsilyloxy) butanoic acid (62). The reaction was 
performed in the same way as 26 using TBDMS-protected ester 61 (2.0 g, 6.97 mmol) 
to afford the pure product 62 (1.59 g, 88%) as a colorless oil. 
1
H NMR (400 MHz, 
CDCl3) δ: 4.27 - 4.23 (m, 1H), 3.40 - 3.27 (m, 2H), 2.66 - 2.54 (m, 2H), 0.89 (s, 9H), 
0.13 (s, 3H), 0.10 (s, 3H). 
13
C NMR (100 MHz, CDCl3) δ: 177.74, 68.67, 56.44, 40.14, 
25.86, 18.13, -4.47, -4.84. 
 
(S)-S-phenyl 4-azido-3-(tert-butyldimethylsilyloxy) butanethioate (63). The 
reaction and silica gel chromatography were performed in the same way as 27 using 
TBDMS-protected acid 62 (1.22 g, 4.71 mmol) to afford the pure product 63 (1.27 g, 
77%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ:7.41 (s, 5H), 4.33 - 4.29 (m, 
1H), 3.41 - 3.21 (m, 2H), 2.90 - 2.88 (m, 2H), 0.91 (s, 9H), 0.12 (s, 3H), 0.10 (s, 3H). 
13
C NMR (100 MHz, CDCl3) δ: 195.17, 134.62, 134.46, 129.84, 129.70, 129.51, 
127.65, 69.03, 56.57, 48.79, 26.00, 18.23, -4.44, -4.68. 
 
(S)-S-phenyl 4-azido-3-hydroxybutane thioate (64). The reaction and silica gel 
chromatography were performed in the same way as 28 using TBDMS-protected 
thiolester 63 (1.05 g, 2.99 mmol) to afford the pure product 64 (673 mg, 95%) as a 
colorless oil. 
1
H NMR (400 MHz, CDCl3) δ: 7.44 (s, 5H), 4.31 - 4.25 (m, 1H), 3.42 - 
3.34 (m, 2H), 2.97 - 2.85 (m, 3H). 
13
C NMR (100 MHz, CDCl3) δ: 197.42, 135.66, 
130.12, 129.63, 126.89, 67.99, 55.69, 47.25. 
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Synthesis of CoA analog (65). The reaction and purification were performed in the 
same way as 29 using (S)-S-phenyl 4-azido-3-hydroxybutane thioate 64 (1.0 mmol) 
and HSCoA (80 mg, 0.1 mmol) to afford the CoA analog 65 as a white solid (59 mg, 
66% yield based on UV absorbance, HPLC: tR = 17.8 min). NMR (400 MHz, D2O) δ: 
8.53 (s, 1H), 8.25 (s, 1H), 6.16 (d, 1H, J = 4.0 Hz), 4.57 (s, 1H), 4.22 (m, 3H), 3.99 (s, 
1H), 3.80 (m, 1H), 3.54 (m, 1H), 3.43 (t, 2H, J = 4.0 Hz), 3.39 (d, 1H, J = 4.0 Hz), 
3.31 (t, 2H, J = 8.0 Hz), 2.99 (t, 2H, J = 8.0 Hz), 2.80 (m, 2H), 2.41 (t, 2H, J = 4.0 
Hz), 0.87 (s, 3H), 0.74 (s, 3H). 
31
P NMR (161 MHz, D2O) δ: 1.70 (s, 1H), -9.72 (m, 
1H), -10.22 (m, 1H). 
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